CA2260774C - Derives de triazolo-pyridazine substitues servant de ligands pour recepteurs de gaba - Google Patents
Derives de triazolo-pyridazine substitues servant de ligands pour recepteurs de gaba Download PDFInfo
- Publication number
- CA2260774C CA2260774C CA002260774A CA2260774A CA2260774C CA 2260774 C CA2260774 C CA 2260774C CA 002260774 A CA002260774 A CA 002260774A CA 2260774 A CA2260774 A CA 2260774A CA 2260774 C CA2260774 C CA 2260774C
- Authority
- CA
- Canada
- Prior art keywords
- triazolo
- phenyl
- pyridazine
- methyl
- ylmethoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003446 ligand Substances 0.000 title abstract description 7
- CBHTTYDJRXOHHL-UHFFFAOYSA-N 2h-triazolo[4,5-c]pyridazine Chemical class N1=NC=CC2=C1N=NN2 CBHTTYDJRXOHHL-UHFFFAOYSA-N 0.000 title description 7
- 102000005915 GABA Receptors Human genes 0.000 title description 2
- 108010005551 GABA Receptors Proteins 0.000 title description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 24
- 230000002265 prevention Effects 0.000 claims abstract description 23
- 208000019901 Anxiety disease Diseases 0.000 claims abstract description 16
- 230000036506 anxiety Effects 0.000 claims abstract description 14
- 206010010904 Convulsion Diseases 0.000 claims abstract description 13
- 230000036461 convulsion Effects 0.000 claims abstract description 12
- 102000004300 GABA-A Receptors Human genes 0.000 claims abstract 7
- 108090000839 GABA-A Receptors Proteins 0.000 claims abstract 7
- 150000001875 compounds Chemical class 0.000 claims description 523
- -1 C6-10 bicycloalkenyl Chemical group 0.000 claims description 311
- 238000000034 method Methods 0.000 claims description 227
- 239000000203 mixture Substances 0.000 claims description 135
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims description 76
- 150000003839 salts Chemical class 0.000 claims description 51
- 239000000651 prodrug Substances 0.000 claims description 43
- 229940002612 prodrug Drugs 0.000 claims description 43
- 125000004076 pyridyl group Chemical group 0.000 claims description 35
- 125000003118 aryl group Chemical group 0.000 claims description 27
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 25
- 239000001257 hydrogen Substances 0.000 claims description 24
- 229910052739 hydrogen Inorganic materials 0.000 claims description 24
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 24
- 230000027455 binding Effects 0.000 claims description 21
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 20
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims description 20
- 125000001072 heteroaryl group Chemical group 0.000 claims description 19
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 17
- 125000004432 carbon atom Chemical group C* 0.000 claims description 15
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 15
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 15
- 230000004044 response Effects 0.000 claims description 15
- 125000000335 thiazolyl group Chemical group 0.000 claims description 15
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 12
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 11
- 238000012360 testing method Methods 0.000 claims description 11
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 claims description 10
- 229940049706 benzodiazepine Drugs 0.000 claims description 10
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 10
- 239000003937 drug carrier Substances 0.000 claims description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 9
- 125000002883 imidazolyl group Chemical group 0.000 claims description 9
- 125000001544 thienyl group Chemical group 0.000 claims description 9
- 125000002541 furyl group Chemical group 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 239000008194 pharmaceutical composition Substances 0.000 claims description 8
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 8
- 239000002249 anxiolytic agent Substances 0.000 claims description 7
- 230000000949 anxiolytic effect Effects 0.000 claims description 7
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 7
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 7
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 6
- 206010039897 Sedation Diseases 0.000 claims description 6
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 6
- 230000036280 sedation Effects 0.000 claims description 6
- 125000004853 tetrahydropyridinyl group Chemical group N1(CCCC=C1)* 0.000 claims description 6
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- NAHDCPURDJHFAG-UHFFFAOYSA-N 6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-3-thiophen-2-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2SC=CC=2)C=2C=CC=CC=2)=N1 NAHDCPURDJHFAG-UHFFFAOYSA-N 0.000 claims description 4
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- 230000001624 sedative effect Effects 0.000 claims description 4
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 4
- STZAMPDZKQQFBF-UHFFFAOYSA-N 2-[(7-cyclobutyl-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy]acetonitrile Chemical compound N#CCOC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1CCC1 STZAMPDZKQQFBF-UHFFFAOYSA-N 0.000 claims description 3
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 claims description 3
- WEJVWILDQNWNJW-UHFFFAOYSA-N 3,7-diphenyl-6-(2h-triazol-4-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C1=NNN=C1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 WEJVWILDQNWNJW-UHFFFAOYSA-N 0.000 claims description 3
- QLJFGMLCGLIGSZ-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-7-(1-methylcyclopentyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C(=CC(F)=CC=2)F)C2(C)CCCC2)=N1 QLJFGMLCGLIGSZ-UHFFFAOYSA-N 0.000 claims description 3
- GQZORSSJIAKBEJ-UHFFFAOYSA-N 3-(2-fluorophenyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C(=CC=CC=2)F)C=2C=CC=CC=2)=N1 GQZORSSJIAKBEJ-UHFFFAOYSA-N 0.000 claims description 3
- DKJVVUVRFFFLLC-UHFFFAOYSA-N 4-[6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-thiophen-2-yl-[1,2,4]triazolo[4,3-b]pyridazin-7-yl]morpholine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2SC=CC=2)N2CCOCC2)=N1 DKJVVUVRFFFLLC-UHFFFAOYSA-N 0.000 claims description 3
- ZQTRFFPESLNLHA-UHFFFAOYSA-N 6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-7-pyrrolidin-1-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)N2CCCC2)=NN2C1=NN=C2C1=CC=CC=C1 ZQTRFFPESLNLHA-UHFFFAOYSA-N 0.000 claims description 3
- OTYBGZZAPBCLPB-UHFFFAOYSA-N 6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-7-thiophen-2-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C=2SC=CC=2)=NN2C1=NN=C2C1=CC=CC=C1 OTYBGZZAPBCLPB-UHFFFAOYSA-N 0.000 claims description 3
- HOCBROYEBQFDGA-UHFFFAOYSA-N 7-cyclobutyl-3-phenyl-6-prop-2-ynoxy-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C#CCOC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1CCC1 HOCBROYEBQFDGA-UHFFFAOYSA-N 0.000 claims description 3
- VACJUKKURQMWHE-UHFFFAOYSA-N 7-cyclobutyl-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2CCC2)=NN2C1=NN=C2C1=CC=CC=C1 VACJUKKURQMWHE-UHFFFAOYSA-N 0.000 claims description 3
- GFMZKHHVXNWGOW-UHFFFAOYSA-N 7-methyl-3-phenyl-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N12N=C(OCC=3N=CC=CC=3)C(C)=CC2=NN=C1C1=CC=CC=C1 GFMZKHHVXNWGOW-UHFFFAOYSA-N 0.000 claims description 3
- 239000004160 Ammonium persulphate Substances 0.000 claims description 3
- 235000019395 ammonium persulphate Nutrition 0.000 claims description 3
- 238000010561 standard procedure Methods 0.000 claims description 3
- 229910052723 transition metal Inorganic materials 0.000 claims description 3
- 150000003624 transition metals Chemical class 0.000 claims description 3
- MMDIHJNGUCQPFF-UHFFFAOYSA-N 2-[(3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxymethyl]-5-methyl-1,3-thiazole Chemical compound S1C(C)=CN=C1COC(C(=C1)C=2C=CC=CC=2)=NN2C1=NN=C2C1=CC=CC=C1 MMDIHJNGUCQPFF-UHFFFAOYSA-N 0.000 claims description 2
- VNAOXTIBJQHVRM-UHFFFAOYSA-N 2-[3-[(3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxymethyl]-1,2,4-triazol-1-yl]-n,n-dimethylacetamide Chemical compound CN(C)C(=O)CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 VNAOXTIBJQHVRM-UHFFFAOYSA-N 0.000 claims description 2
- HWGNAWBPLYPUJG-UHFFFAOYSA-N 2-[3-[(3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxymethyl]-1,2,4-triazol-1-yl]-n,n-dimethylethanamine Chemical compound CN(C)CCN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 HWGNAWBPLYPUJG-UHFFFAOYSA-N 0.000 claims description 2
- GIUNTDNEYLMTBV-UHFFFAOYSA-N 2-[3-[(3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxymethyl]-1,2,4-triazol-1-yl]acetonitrile Chemical compound N#CCN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 GIUNTDNEYLMTBV-UHFFFAOYSA-N 0.000 claims description 2
- YPYNGKVFEWEQPN-UHFFFAOYSA-N 2-[3-[(3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxymethyl]-1,2,4-triazol-1-yl]ethanamine Chemical compound NCCN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 YPYNGKVFEWEQPN-UHFFFAOYSA-N 0.000 claims description 2
- AAFRVZSZEIHNAI-UHFFFAOYSA-N 3,7-diphenyl-6-(1h-1,2,4-triazol-5-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1C=NNC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 AAFRVZSZEIHNAI-UHFFFAOYSA-N 0.000 claims description 2
- WOLTXCLEGCMVNA-UHFFFAOYSA-N 3,7-diphenyl-6-(pyrazin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1N=CC=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 WOLTXCLEGCMVNA-UHFFFAOYSA-N 0.000 claims description 2
- DHVVPBUFVXPPMP-UHFFFAOYSA-N 3,7-diphenyl-6-(pyridazin-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1C=CN=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 DHVVPBUFVXPPMP-UHFFFAOYSA-N 0.000 claims description 2
- OIVNHVRINWMDTH-UHFFFAOYSA-N 3,7-diphenyl-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1C=CC=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 OIVNHVRINWMDTH-UHFFFAOYSA-N 0.000 claims description 2
- RCAREXJZVVHPHV-UHFFFAOYSA-N 3,7-diphenyl-6-(pyrimidin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1C=CC=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 RCAREXJZVVHPHV-UHFFFAOYSA-N 0.000 claims description 2
- MYJSELOFPLYFEG-UHFFFAOYSA-N 3,7-diphenyl-6-(pyrimidin-4-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1C=NC=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 MYJSELOFPLYFEG-UHFFFAOYSA-N 0.000 claims description 2
- DQPAAFTXZFHSMD-UHFFFAOYSA-N 3,7-diphenyl-6-(pyrimidin-5-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1N=CN=CC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 DQPAAFTXZFHSMD-UHFFFAOYSA-N 0.000 claims description 2
- LYGWGPHLTGKDDZ-UHFFFAOYSA-N 3,7-diphenyl-6-[(1-propyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CCCN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 LYGWGPHLTGKDDZ-UHFFFAOYSA-N 0.000 claims description 2
- WRWXYWQNZNBPRI-UHFFFAOYSA-N 3,7-diphenyl-6-[[1-(2-piperazin-1-ylethyl)-1,2,4-triazol-3-yl]methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C1CNCCN1CCN(N=1)C=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 WRWXYWQNZNBPRI-UHFFFAOYSA-N 0.000 claims description 2
- KCSTVGDYVKXIJT-UHFFFAOYSA-N 3,7-diphenyl-6-[[1-(2-pyrrolidin-1-ylethyl)-1,2,4-triazol-3-yl]methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C1CCCN1CCN(N=1)C=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 KCSTVGDYVKXIJT-UHFFFAOYSA-N 0.000 claims description 2
- VXIUXRNTQNASBZ-UHFFFAOYSA-N 3,7-diphenyl-6-[[1-(pyridin-2-ylmethyl)-1,2,4-triazol-3-yl]methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N1=CN(CC=2N=CC=CC=2)N=C1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 VXIUXRNTQNASBZ-UHFFFAOYSA-N 0.000 claims description 2
- BFUOYOXAUFRHJA-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-7-(1-methylcyclopentyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2(C)CCCC2)=NN2C1=NN=C2C1=CC=C(F)C=C1F BFUOYOXAUFRHJA-UHFFFAOYSA-N 0.000 claims description 2
- RFHYKWWROVNBBX-UHFFFAOYSA-N 3-(2-fluorophenyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-7-thiophen-3-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C(=CC=CC=2)F)C2=CSC=C2)=N1 RFHYKWWROVNBBX-UHFFFAOYSA-N 0.000 claims description 2
- WBGFZYZIMGCWRS-UHFFFAOYSA-N 3-(2-fluorophenyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C=2C=CC=CC=2)=NN2C1=NN=C2C1=CC=CC=C1F WBGFZYZIMGCWRS-UHFFFAOYSA-N 0.000 claims description 2
- MCASNKXBBBTTOS-UHFFFAOYSA-N 3-(2-fluorophenyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-7-thiophen-3-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2=CSC=C2)=NN2C1=NN=C2C1=CC=CC=C1F MCASNKXBBBTTOS-UHFFFAOYSA-N 0.000 claims description 2
- PCWJWLZHLADFLD-UHFFFAOYSA-N 3-(2-fluorophenyl)-7-(1-methylcyclobutyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C(=CC=CC=2)F)C2(C)CCC2)=N1 PCWJWLZHLADFLD-UHFFFAOYSA-N 0.000 claims description 2
- UFULYACRJFODBY-UHFFFAOYSA-N 3-(2-fluorophenyl)-7-(1-methylcyclobutyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2(C)CCC2)=NN2C1=NN=C2C1=CC=CC=C1F UFULYACRJFODBY-UHFFFAOYSA-N 0.000 claims description 2
- ZBPFNELZLABPJO-UHFFFAOYSA-N 3-(2-fluorophenyl)-7-(1-methylcyclopentyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C(=CC=CC=2)F)C2(C)CCCC2)=N1 ZBPFNELZLABPJO-UHFFFAOYSA-N 0.000 claims description 2
- FRXCYAPNCVFQCR-UHFFFAOYSA-N 3-(2-fluorophenyl)-7-(1-methylcyclopentyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2(C)CCCC2)=NN2C1=NN=C2C1=CC=CC=C1F FRXCYAPNCVFQCR-UHFFFAOYSA-N 0.000 claims description 2
- MEVOCWHZYRHURQ-UHFFFAOYSA-N 3-(3-fluorophenyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=C(F)C=CC=2)C=2C=CC=CC=2)=N1 MEVOCWHZYRHURQ-UHFFFAOYSA-N 0.000 claims description 2
- IKZGGLQQGAJSRM-UHFFFAOYSA-N 3-(4-fluorophenyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC(F)=CC=2)C=2C=CC=CC=2)=N1 IKZGGLQQGAJSRM-UHFFFAOYSA-N 0.000 claims description 2
- KQYHETYQOIUNLY-UHFFFAOYSA-N 3-(4-fluorophenyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-7-thiophen-3-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2=CSC=C2)=NN2C1=NN=C2C1=CC=C(F)C=C1 KQYHETYQOIUNLY-UHFFFAOYSA-N 0.000 claims description 2
- FRDBGMYFMSVJDR-UHFFFAOYSA-N 3-(4-methoxyphenyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C1=CC(OC)=CC=C1C1=NN=C2N1N=C(OCC1=NN(C)C=N1)C(C=1C=CC=CC=1)=C2 FRDBGMYFMSVJDR-UHFFFAOYSA-N 0.000 claims description 2
- HPHNQRHXQRLRLZ-UHFFFAOYSA-N 3-(4-methylphenyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C1=CC(C)=CC=C1C1=NN=C2N1N=C(OCC1=NN(C)C=N1)C(C=1C=CC=CC=1)=C2 HPHNQRHXQRLRLZ-UHFFFAOYSA-N 0.000 claims description 2
- REJBYWVLGVSIGN-UHFFFAOYSA-N 3-(4-methylphenyl)-6-[(3-methylpyridin-2-yl)methoxy]-7-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C1=CC(C)=CC=C1C1=NN=C2N1N=C(OCC=1C(=CC=CN=1)C)C(C=1C=CC=CC=1)=C2 REJBYWVLGVSIGN-UHFFFAOYSA-N 0.000 claims description 2
- UHJNPZTZEYIENC-UHFFFAOYSA-N 3-(4-methylphenyl)-7-phenyl-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C1=CC(C)=CC=C1C1=NN=C2N1N=C(OCC=1N=CC=CC=1)C(C=1C=CC=CC=1)=C2 UHJNPZTZEYIENC-UHFFFAOYSA-N 0.000 claims description 2
- RRAWTSZJLAMHFE-UHFFFAOYSA-N 3-(furan-2-yl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2OC=CC=2)C=2C=CC=CC=2)=N1 RRAWTSZJLAMHFE-UHFFFAOYSA-N 0.000 claims description 2
- ZBIZEDUBXBVVDX-UHFFFAOYSA-N 3-(furan-3-yl)-6-(pyridin-2-ylmethoxy)-7,8,9,10-tetrahydro-[1,2,4]triazolo[3,4-a]phthalazine Chemical compound C=1C=CC=NC=1COC(C=1CCCCC=1C1=NN=2)=NN1C=2C=1C=COC=1 ZBIZEDUBXBVVDX-UHFFFAOYSA-N 0.000 claims description 2
- CRFYXSJVEFOVJZ-UHFFFAOYSA-N 3-[(3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxymethyl]-5-methyl-1,2-oxazole Chemical compound O1C(C)=CC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 CRFYXSJVEFOVJZ-UHFFFAOYSA-N 0.000 claims description 2
- FCFAREUMSQVSLJ-UHFFFAOYSA-N 3-cyclopropyl-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C2CC2)C=2C=CC=CC=2)=N1 FCFAREUMSQVSLJ-UHFFFAOYSA-N 0.000 claims description 2
- ZPSBXQBYCQOCEU-UHFFFAOYSA-N 3-phenyl-6-(pyridin-2-ylmethoxy)-7,8,9,10-tetrahydro-[1,2,4]triazolo[3,4-a]phthalazine Chemical compound C=1C=CC=NC=1COC(C=1CCCCC=1C1=NN=2)=NN1C=2C1=CC=CC=C1 ZPSBXQBYCQOCEU-UHFFFAOYSA-N 0.000 claims description 2
- AVDYSIRPQQXPMM-UHFFFAOYSA-N 3-phenyl-6-(pyridin-2-ylmethoxy)-7-thiophen-2-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1C=CC=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CS1 AVDYSIRPQQXPMM-UHFFFAOYSA-N 0.000 claims description 2
- NCBOIASFLNJMTE-UHFFFAOYSA-N 3-phenyl-7-piperidin-1-yl-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1C=CC=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1N1CCCCC1 NCBOIASFLNJMTE-UHFFFAOYSA-N 0.000 claims description 2
- CEKCQRZLMWJFHB-UHFFFAOYSA-N 3-phenyl-7-pyridin-3-yl-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1C=CC=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CN=C1 CEKCQRZLMWJFHB-UHFFFAOYSA-N 0.000 claims description 2
- IDEZPOJTOXGVQI-UHFFFAOYSA-N 3-phenyl-7-thiophen-3-yl-6-(1h-1,2,4-triazol-5-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1C=NNC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C=1C=CSC=1 IDEZPOJTOXGVQI-UHFFFAOYSA-N 0.000 claims description 2
- JQSZTNICLOUIPD-UHFFFAOYSA-N 4-[(3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxymethyl]-1,3-thiazole Chemical compound C=1SC=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 JQSZTNICLOUIPD-UHFFFAOYSA-N 0.000 claims description 2
- LZRYKBWTOGDZRQ-UHFFFAOYSA-N 4-[2-[3-[(3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxymethyl]-1,2,4-triazol-1-yl]ethyl]morpholine Chemical compound C1COCCN1CCN(N=1)C=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 LZRYKBWTOGDZRQ-UHFFFAOYSA-N 0.000 claims description 2
- UALFGPVTWGMBCB-UHFFFAOYSA-N 4-[3-(3-fluorophenyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazin-7-yl]morpholine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=C(F)C=CC=2)N2CCOCC2)=N1 UALFGPVTWGMBCB-UHFFFAOYSA-N 0.000 claims description 2
- GSQTYKQADBTZAF-UHFFFAOYSA-N 4-[3-phenyl-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazin-7-yl]morpholine Chemical compound C=1C=CC=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1N1CCOCC1 GSQTYKQADBTZAF-UHFFFAOYSA-N 0.000 claims description 2
- LTMYXBJRKUILMN-UHFFFAOYSA-N 4-[4-[(7-cyclobutyl-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy]but-2-ynyl]-2,6-dimethylmorpholine Chemical compound C1C(C)OC(C)CN1CC#CCOC(C(=C1)C2CCC2)=NN2C1=NN=C2C1=CC=CC=C1 LTMYXBJRKUILMN-UHFFFAOYSA-N 0.000 claims description 2
- IUEGWDIGIFAMBR-UHFFFAOYSA-N 4-[6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-7-yl]morpholine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)N2CCOCC2)=N1 IUEGWDIGIFAMBR-UHFFFAOYSA-N 0.000 claims description 2
- VDORHDUUIQZRDL-UHFFFAOYSA-N 5-[2-[(3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxy]ethyl]-4-methyl-1,3-thiazole Chemical compound N1=CSC(CCOC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1C VDORHDUUIQZRDL-UHFFFAOYSA-N 0.000 claims description 2
- SIYUIIGNHRAJJA-UHFFFAOYSA-N 6-(1h-benzimidazol-2-ylmethoxy)-3-(2,4-difluorophenyl)-7-(1-methylcyclopentyl)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1C2=NN=C(C=3C(=CC(F)=CC=3)F)N2N=C(OCC=2NC3=CC=CC=C3N=2)C=1C1(C)CCCC1 SIYUIIGNHRAJJA-UHFFFAOYSA-N 0.000 claims description 2
- MDTDCBJLYUNWJT-UHFFFAOYSA-N 6-[(1-benzyl-1,2,4-triazol-3-yl)methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N1=CN(CC=2C=CC=CC=2)N=C1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 MDTDCBJLYUNWJT-UHFFFAOYSA-N 0.000 claims description 2
- LDIXKOVZSSLYMJ-UHFFFAOYSA-N 6-[(1-ethylimidazol-2-yl)methoxy]-3-(4-methylphenyl)-7-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CCN1C=CN=C1COC(C(=C1)C=2C=CC=CC=2)=NN2C1=NN=C2C1=CC=C(C)C=C1 LDIXKOVZSSLYMJ-UHFFFAOYSA-N 0.000 claims description 2
- RIXHBDMRLPVSEE-UHFFFAOYSA-N 6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 RIXHBDMRLPVSEE-UHFFFAOYSA-N 0.000 claims description 2
- VJYHJBZTXOLVMU-UHFFFAOYSA-N 6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-7-propan-2-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N12N=C(OCC3=NN(C)C=N3)C(C(C)C)=CC2=NN=C1C1=CC=CC=C1 VJYHJBZTXOLVMU-UHFFFAOYSA-N 0.000 claims description 2
- JKWLECBCROPOMV-UHFFFAOYSA-N 6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-7-pyridin-4-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CN=CC=2)=N1 JKWLECBCROPOMV-UHFFFAOYSA-N 0.000 claims description 2
- NABBTMMFXIVNLD-UHFFFAOYSA-N 6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-7-pyrrolidin-1-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)N2CCCC2)=N1 NABBTMMFXIVNLD-UHFFFAOYSA-N 0.000 claims description 2
- DEEIDXBPQNUNGZ-UHFFFAOYSA-N 6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-7-thiophen-2-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2SC=CC=2)=N1 DEEIDXBPQNUNGZ-UHFFFAOYSA-N 0.000 claims description 2
- RYHZVZSDMUNURQ-UHFFFAOYSA-N 6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-7-thiophen-3-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C2=CSC=C2)=N1 RYHZVZSDMUNURQ-UHFFFAOYSA-N 0.000 claims description 2
- SSQNGBXFKQFNSC-UHFFFAOYSA-N 6-[(1-methylimidazol-4-yl)methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=C1 SSQNGBXFKQFNSC-UHFFFAOYSA-N 0.000 claims description 2
- LHMYCKKRCBXCBI-UHFFFAOYSA-N 6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C=2C=CC=CC=2)=NN2C1=NN=C2C1=CC=CC=C1 LHMYCKKRCBXCBI-UHFFFAOYSA-N 0.000 claims description 2
- VBIUWFXJSGIEKL-UHFFFAOYSA-N 6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-7-propan-2-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N12N=C(OCC=3N(N=CN=3)C)C(C(C)C)=CC2=NN=C1C1=CC=CC=C1 VBIUWFXJSGIEKL-UHFFFAOYSA-N 0.000 claims description 2
- NJSIZMUEMYUQFZ-UHFFFAOYSA-N 6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-3-pyridin-3-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C=2C=CC=CC=2)=NN2C1=NN=C2C1=CC=CN=C1 NJSIZMUEMYUQFZ-UHFFFAOYSA-N 0.000 claims description 2
- FLWIFTLBIHIEOW-UHFFFAOYSA-N 6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-7-thiophen-3-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2=CSC=C2)=NN2C1=NN=C2 FLWIFTLBIHIEOW-UHFFFAOYSA-N 0.000 claims description 2
- CXJRNDIMOTWWJA-UHFFFAOYSA-N 6-[(2-methyltetrazol-5-yl)methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 CXJRNDIMOTWWJA-UHFFFAOYSA-N 0.000 claims description 2
- GCVRJJZTGPVPAD-UHFFFAOYSA-N 6-[(3-methylimidazol-4-yl)methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC=C1COC(C(=C1)C=2C=CC=CC=2)=NN2C1=NN=C2C1=CC=CC=C1 GCVRJJZTGPVPAD-UHFFFAOYSA-N 0.000 claims description 2
- LKJQVAJICVZOQT-UHFFFAOYSA-N 6-[(3-methylpyridin-2-yl)methoxy]-3-phenyl-7-piperidin-1-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CC1=CC=CN=C1COC(C(=C1)N2CCCCC2)=NN2C1=NN=C2C1=CC=CC=C1 LKJQVAJICVZOQT-UHFFFAOYSA-N 0.000 claims description 2
- LTHHNAJLVMPSRA-UHFFFAOYSA-N 6-[(4-methyl-1,2,4-triazol-3-yl)methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NN=C1COC(C(=C1)C=2C=CC=CC=2)=NN2C1=NN=C2C1=CC=CC=C1 LTHHNAJLVMPSRA-UHFFFAOYSA-N 0.000 claims description 2
- MGIHNTDQHRDPQF-UHFFFAOYSA-N 6-[(5-methyl-1h-1,2,4-triazol-3-yl)methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CC1=NNC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 MGIHNTDQHRDPQF-UHFFFAOYSA-N 0.000 claims description 2
- USZJBAPIJYTILI-UHFFFAOYSA-N 6-[[1-(1-methylpiperidin-4-yl)-1,2,4-triazol-3-yl]methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C1CN(C)CCC1N1N=C(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)N=C1 USZJBAPIJYTILI-UHFFFAOYSA-N 0.000 claims description 2
- YIXXOJVMOQDGNI-UHFFFAOYSA-N 7,8-dimethyl-3-phenyl-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1N2C(C=3C=CC=CC=3)=NN=C2C(C)=C(C)C=1OCC1=CC=CC=N1 YIXXOJVMOQDGNI-UHFFFAOYSA-N 0.000 claims description 2
- OXPVLJHRJBFDQB-UHFFFAOYSA-N 7-(1-methylcyclobutyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C2(C)CCC2)=N1 OXPVLJHRJBFDQB-UHFFFAOYSA-N 0.000 claims description 2
- CFOOYYMKAMEJBL-UHFFFAOYSA-N 7-(1-methylcyclobutyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2(C)CCC2)=NN2C1=NN=C2C1=CC=CC=C1 CFOOYYMKAMEJBL-UHFFFAOYSA-N 0.000 claims description 2
- XMTHRPGPSUJCCG-UHFFFAOYSA-N 7-(1-methylcyclopentyl)-6-[(3-methylpyridin-2-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CC1=CC=CN=C1COC(C(=C1)C2(C)CCCC2)=NN2C1=NN=C2C1=CC=CC=C1 XMTHRPGPSUJCCG-UHFFFAOYSA-N 0.000 claims description 2
- KRNIZJFCJNEAMC-UHFFFAOYSA-N 7-(1-methylcyclopropyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C2(C)CC2)=N1 KRNIZJFCJNEAMC-UHFFFAOYSA-N 0.000 claims description 2
- YUNYEPKAWNWTCM-UHFFFAOYSA-N 7-(2-methylbutan-2-yl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N12N=C(OCC3=NN(C)C=N3)C(C(C)(C)CC)=CC2=NN=C1C1=CC=CC=C1 YUNYEPKAWNWTCM-UHFFFAOYSA-N 0.000 claims description 2
- XPMNJDCXQMPCIO-UHFFFAOYSA-N 7-(5-chlorothiophen-2-yl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C=2SC(Cl)=CC=2)=NN2C1=NN=C2C1=CC=CC=C1 XPMNJDCXQMPCIO-UHFFFAOYSA-N 0.000 claims description 2
- YTVKHJZQLGIKCE-UHFFFAOYSA-N 7-(furan-2-yl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2OC=CC=2)=N1 YTVKHJZQLGIKCE-UHFFFAOYSA-N 0.000 claims description 2
- QUDANIBRZAJEHA-UHFFFAOYSA-N 7-(furan-2-yl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C=2OC=CC=2)=NN2C1=NN=C2C1=CC=CC=C1 QUDANIBRZAJEHA-UHFFFAOYSA-N 0.000 claims description 2
- WFQGCGNGOVKICN-UHFFFAOYSA-N 7-cyclobutyl-3-phenyl-6-(1h-1,2,4-triazol-5-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1C=NNC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1CCC1 WFQGCGNGOVKICN-UHFFFAOYSA-N 0.000 claims description 2
- RJTIKEAHSDDBFU-UHFFFAOYSA-N 7-cyclobutyl-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C2CCC2)=N1 RJTIKEAHSDDBFU-UHFFFAOYSA-N 0.000 claims description 2
- NRVMDUPYHCGRQW-UHFFFAOYSA-N 7-cyclobutyl-8-methyl-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N1=CN(C)N=C1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C(C)=C1C1CCC1 NRVMDUPYHCGRQW-UHFFFAOYSA-N 0.000 claims description 2
- FFPOLBVOCSSYCJ-UHFFFAOYSA-N 7-cyclobutyl-8-methyl-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1C=NN(C)C=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C(C)=C1C1CCC1 FFPOLBVOCSSYCJ-UHFFFAOYSA-N 0.000 claims description 2
- XXDJXHYFDGGRRZ-UHFFFAOYSA-N 7-cyclohexyl-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C2CCCCC2)=N1 XXDJXHYFDGGRRZ-UHFFFAOYSA-N 0.000 claims description 2
- YLPHFEFMBAMSKS-UHFFFAOYSA-N 7-cyclohexyl-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2CCCCC2)=NN2C1=NN=C2C1=CC=CC=C1 YLPHFEFMBAMSKS-UHFFFAOYSA-N 0.000 claims description 2
- FPKLVZXGBZJJNX-UHFFFAOYSA-N 7-cyclopentyl-3-(2,4-difluorophenyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C(=CC(F)=CC=2)F)C2CCCC2)=N1 FPKLVZXGBZJJNX-UHFFFAOYSA-N 0.000 claims description 2
- SXFKAOHJTVSOPJ-UHFFFAOYSA-N 7-cyclopentyl-3-(2,4-difluorophenyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2CCCC2)=NN2C1=NN=C2C1=CC=C(F)C=C1F SXFKAOHJTVSOPJ-UHFFFAOYSA-N 0.000 claims description 2
- OHSIIKNYYFSTJF-UHFFFAOYSA-N 7-cyclopentyl-3-(2-fluorophenyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C(=CC=CC=2)F)C2CCCC2)=N1 OHSIIKNYYFSTJF-UHFFFAOYSA-N 0.000 claims description 2
- DVIJGLIEZLXACB-UHFFFAOYSA-N 7-cyclopentyl-3-(2-fluorophenyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2CCCC2)=NN2C1=NN=C2C1=CC=CC=C1F DVIJGLIEZLXACB-UHFFFAOYSA-N 0.000 claims description 2
- PRWJSLUUGOBAFN-UHFFFAOYSA-N 7-cyclopentyl-3-(furan-2-yl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2OC=CC=2)C2CCCC2)=N1 PRWJSLUUGOBAFN-UHFFFAOYSA-N 0.000 claims description 2
- NKRMWVWOOQBTCY-UHFFFAOYSA-N 7-cyclopentyl-3-(furan-2-yl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2CCCC2)=NN2C1=NN=C2C1=CC=CO1 NKRMWVWOOQBTCY-UHFFFAOYSA-N 0.000 claims description 2
- KWRCOLOBBLMFAP-UHFFFAOYSA-N 7-cyclopentyl-3-phenyl-6-(1h-1,2,4-triazol-5-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1C=NNC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1CCCC1 KWRCOLOBBLMFAP-UHFFFAOYSA-N 0.000 claims description 2
- IUDSPISXHWGEOI-UHFFFAOYSA-N 7-cyclopentyl-3-phenyl-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1C=CC=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1CCCC1 IUDSPISXHWGEOI-UHFFFAOYSA-N 0.000 claims description 2
- GXQDLUZEKJYFQO-UHFFFAOYSA-N 7-cyclopentyl-6-(pyridin-2-ylmethoxy)-3-thiophen-2-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1C=CC=NC=1COC1=NN2C(C=3SC=CC=3)=NN=C2C=C1C1CCCC1 GXQDLUZEKJYFQO-UHFFFAOYSA-N 0.000 claims description 2
- XPANKLKOSFBPSJ-UHFFFAOYSA-N 7-cyclopentyl-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C2CCCC2)=N1 XPANKLKOSFBPSJ-UHFFFAOYSA-N 0.000 claims description 2
- CMSKDYKEKYIJSD-UHFFFAOYSA-N 7-cyclopentyl-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2CCCC2)=NN2C1=NN=C2C1=CC=CC=C1 CMSKDYKEKYIJSD-UHFFFAOYSA-N 0.000 claims description 2
- BWXDDFASLOAGES-UHFFFAOYSA-N 7-cyclopentyl-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-pyridin-4-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2CCCC2)=NN2C1=NN=C2C1=CC=NC=C1 BWXDDFASLOAGES-UHFFFAOYSA-N 0.000 claims description 2
- HBZNQGWSCQNEBB-UHFFFAOYSA-N 7-cyclopentyl-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-thiophen-2-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2CCCC2)=NN2C1=NN=C2C1=CC=CS1 HBZNQGWSCQNEBB-UHFFFAOYSA-N 0.000 claims description 2
- LAQDWWWMZAJCPN-UHFFFAOYSA-N 7-cyclopentyl-8-methyl-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1C=NN(C)C=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C(C)=C1C1CCCC1 LAQDWWWMZAJCPN-UHFFFAOYSA-N 0.000 claims description 2
- SJKIGZBTHJVWLJ-UHFFFAOYSA-N 7-ethyl-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N12N=C(OCC3=NN(C)C=N3)C(CC)=CC2=NN=C1C1=CC=CC=C1 SJKIGZBTHJVWLJ-UHFFFAOYSA-N 0.000 claims description 2
- KUZSRQBJRMHMFJ-UHFFFAOYSA-N 7-ethyl-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N12N=C(OCC=3N(N=CN=3)C)C(CC)=CC2=NN=C1C1=CC=CC=C1 KUZSRQBJRMHMFJ-UHFFFAOYSA-N 0.000 claims description 2
- YIPQSMMRTUWGQF-UHFFFAOYSA-N 7-methyl-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N12N=C(OCC3=NN(C)C=N3)C(C)=CC2=NN=C1C1=CC=CC=C1 YIPQSMMRTUWGQF-UHFFFAOYSA-N 0.000 claims description 2
- CDBMINRIXDAEIM-UHFFFAOYSA-N 7-phenyl-3-thiophen-2-yl-6-(1h-1,2,4-triazol-5-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1C=NNC=1COC1=NN2C(C=3SC=CC=3)=NN=C2C=C1C1=CC=CC=C1 CDBMINRIXDAEIM-UHFFFAOYSA-N 0.000 claims description 2
- XCTVOZPAIUDJLQ-UHFFFAOYSA-N 7-tert-butyl-3-(2-fluorophenyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C(=CC=CC=2)F)C(C)(C)C)=N1 XCTVOZPAIUDJLQ-UHFFFAOYSA-N 0.000 claims description 2
- FPKKOCPCXRSNQZ-UHFFFAOYSA-N 7-tert-butyl-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C(C)(C)C)=N1 FPKKOCPCXRSNQZ-UHFFFAOYSA-N 0.000 claims description 2
- QQYWRGWYGIQFOJ-UHFFFAOYSA-N 8-methyl-3,7-diphenyl-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1N2C(C=3C=CC=CC=3)=NN=C2C(C)=C(C=2C=CC=CC=2)C=1OCC1=CC=CC=N1 QQYWRGWYGIQFOJ-UHFFFAOYSA-N 0.000 claims description 2
- SZQXUWZXEPBTHY-UHFFFAOYSA-N 8-methyl-3-phenyl-6-(pyridin-2-ylmethoxy)-7,8,9,10-tetrahydro-[1,2,4]triazolo[3,4-a]phthalazine Chemical compound C1C(C)CCC(C2=NN=C(N2N=2)C=3C=CC=CC=3)=C1C=2OCC1=CC=CC=N1 SZQXUWZXEPBTHY-UHFFFAOYSA-N 0.000 claims description 2
- ZUENPPWCLKHVTK-UHFFFAOYSA-N 8-methyl-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1N2C(C=3C=CC=CC=3)=NN=C2C(C)=C(C=2C=CC=CC=2)C=1OCC=1N=CN(C)N=1 ZUENPPWCLKHVTK-UHFFFAOYSA-N 0.000 claims description 2
- OHAPCRXXANBYTN-UHFFFAOYSA-N 8-methyl-7-(1-methylcyclobutyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1N2C(C=3C=CC=CC=3)=NN=C2C(C)=C(C2(C)CCC2)C=1OCC=1N=CN(C)N=1 OHAPCRXXANBYTN-UHFFFAOYSA-N 0.000 claims description 2
- YEIFFGBURLJKHG-UHFFFAOYSA-N 8-methyl-7-(1-methylcyclobutyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1N2C(C=3C=CC=CC=3)=NN=C2C(C)=C(C2(C)CCC2)C=1OCC1=NC=NN1C YEIFFGBURLJKHG-UHFFFAOYSA-N 0.000 claims description 2
- 230000009286 beneficial effect Effects 0.000 claims description 2
- PNAKKMVFYJCHMZ-UHFFFAOYSA-N n,n-diethyl-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-7-amine Chemical compound N12N=C(OCC3=NN(C)C=N3)C(N(CC)CC)=CC2=NN=C1C1=CC=CC=C1 PNAKKMVFYJCHMZ-UHFFFAOYSA-N 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 2
- KDAYAFGPNTXUCS-UHFFFAOYSA-N 2-[(3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxymethyl]-4-methyl-1,3-thiazole Chemical compound CC1=CSC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 KDAYAFGPNTXUCS-UHFFFAOYSA-N 0.000 claims 1
- RPXIOUYOWINDIB-UHFFFAOYSA-N 3,7-diphenyl-6-[(2-propyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CCCN1N=CN=C1COC(C(=C1)C=2C=CC=CC=2)=NN2C1=NN=C2C1=CC=CC=C1 RPXIOUYOWINDIB-UHFFFAOYSA-N 0.000 claims 1
- QEWCWAZIROCRRH-UHFFFAOYSA-N 3-(4-fluorophenyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-7-thiophen-3-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC(F)=CC=2)C2=CSC=C2)=N1 QEWCWAZIROCRRH-UHFFFAOYSA-N 0.000 claims 1
- RCXZRLWXLRUDFH-UHFFFAOYSA-N 3-(5-methylthiophen-2-yl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound S1C(C)=CC=C1C1=NN=C2N1N=C(OCC1=NN(C)C=N1)C(C=1C=CC=CC=1)=C2 RCXZRLWXLRUDFH-UHFFFAOYSA-N 0.000 claims 1
- UZOHRFHDDLPKKS-UHFFFAOYSA-N 3-[(3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxymethyl]-5-methyl-1,2,4-oxadiazole Chemical compound O1C(C)=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 UZOHRFHDDLPKKS-UHFFFAOYSA-N 0.000 claims 1
- DURXAJILKOQSQM-UHFFFAOYSA-N 3-phenyl-6-(pyridin-2-ylmethoxy)-7-thiophen-3-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1C=CC=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C=1C=CSC=1 DURXAJILKOQSQM-UHFFFAOYSA-N 0.000 claims 1
- JQYSPBXUNCRBJS-UHFFFAOYSA-N 3-phenyl-7-pyridin-4-yl-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1C=CC=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=NC=C1 JQYSPBXUNCRBJS-UHFFFAOYSA-N 0.000 claims 1
- AAWHSIIPXWKJNS-UHFFFAOYSA-N 4-[3-phenyl-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazin-7-yl]thiomorpholine Chemical compound C=1C=CC=NC=1COC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1N1CCSCC1 AAWHSIIPXWKJNS-UHFFFAOYSA-N 0.000 claims 1
- VZFOZTUIYKQSDP-UHFFFAOYSA-N 4-[6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-7-yl]morpholine Chemical compound CN1N=CN=C1COC(C(=C1)N2CCOCC2)=NN2C1=NN=C2C1=CC=CC=C1 VZFOZTUIYKQSDP-UHFFFAOYSA-N 0.000 claims 1
- NZNJEHSFNBLNFP-UHFFFAOYSA-N 5-[(3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)oxymethyl]-3-methyl-1,2,4-oxadiazole Chemical compound CC1=NOC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 NZNJEHSFNBLNFP-UHFFFAOYSA-N 0.000 claims 1
- GEWLTTZNZPUIOR-UHFFFAOYSA-N 6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-3-pyridin-3-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=NC=CC=2)C=2C=CC=CC=2)=N1 GEWLTTZNZPUIOR-UHFFFAOYSA-N 0.000 claims 1
- SVTAFDIHWQPZDR-UHFFFAOYSA-N 6-[(1-methyltriazol-4-yl)methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N1=NN(C)C=C1COC(C(=C1)C=2C=CC=CC=2)=NN2C1=NN=C2C1=CC=CC=C1 SVTAFDIHWQPZDR-UHFFFAOYSA-N 0.000 claims 1
- TWYXCJWUBNYBMK-UHFFFAOYSA-N 6-[(3-methyltriazol-4-yl)methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=NC=C1COC(C(=C1)C=2C=CC=CC=2)=NN2C1=NN=C2C1=CC=CC=C1 TWYXCJWUBNYBMK-UHFFFAOYSA-N 0.000 claims 1
- VXVLSQVFRWSMKF-UHFFFAOYSA-N 6-[(6-methylpyridin-2-yl)methoxy]-3-phenyl-[1,2,4]triazolo[3,4-a]phthalazine Chemical compound CC1=CC=CC(COC=2C3=CC=CC=C3C3=NN=C(N3N=2)C=2C=CC=CC=2)=N1 VXVLSQVFRWSMKF-UHFFFAOYSA-N 0.000 claims 1
- PHYHYDJDDHSJHT-UHFFFAOYSA-N 7-(1-methylcyclopentyl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C2(C)CCCC2)=N1 PHYHYDJDDHSJHT-UHFFFAOYSA-N 0.000 claims 1
- IJHVTPOBVZWJEU-UHFFFAOYSA-N 7-(5-chlorothiophen-2-yl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2SC(Cl)=CC=2)=N1 IJHVTPOBVZWJEU-UHFFFAOYSA-N 0.000 claims 1
- BMTXRWKCEQOKAM-UHFFFAOYSA-N 7-(cyclobuten-1-yl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C=2CCC=2)=NN2C1=NN=C2C1=CC=CC=C1 BMTXRWKCEQOKAM-UHFFFAOYSA-N 0.000 claims 1
- OWBOIJAKHRNFNM-UHFFFAOYSA-N 7-cyclopentyl-3-(2-fluorophenyl)-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound FC1=CC=CC=C1C1=NN=C2N1N=C(OCC=1N=CC=CC=1)C(C1CCCC1)=C2 OWBOIJAKHRNFNM-UHFFFAOYSA-N 0.000 claims 1
- NAPZJLJMVTYFBO-UHFFFAOYSA-N 7-cyclopentyl-3-(4-methoxyphenyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C1=CC(OC)=CC=C1C1=NN=C2N1N=C(OCC=1N(N=CN=1)C)C(C1CCCC1)=C2 NAPZJLJMVTYFBO-UHFFFAOYSA-N 0.000 claims 1
- VVJSGHJWLDLMMJ-UHFFFAOYSA-N 7-cyclopentyl-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-thiophen-2-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2SC=CC=2)C2CCCC2)=N1 VVJSGHJWLDLMMJ-UHFFFAOYSA-N 0.000 claims 1
- IHYDNGHFAUHVCR-UHFFFAOYSA-N 7-ethyl-3-phenyl-6-(pyridin-2-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N12N=C(OCC=3N=CC=CC=3)C(CC)=CC2=NN=C1C1=CC=CC=C1 IHYDNGHFAUHVCR-UHFFFAOYSA-N 0.000 claims 1
- JBOZVRVPCHJHLD-UHFFFAOYSA-N 7-methyl-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N12N=C(OCC=3N(N=CN=3)C)C(C)=CC2=NN=C1C1=CC=CC=C1 JBOZVRVPCHJHLD-UHFFFAOYSA-N 0.000 claims 1
- CUCYVGNNTAIIAN-UHFFFAOYSA-N 7-tert-butyl-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C(C)(C)C)=NN2C1=NN=C2C1=CC=CC=C1 CUCYVGNNTAIIAN-UHFFFAOYSA-N 0.000 claims 1
- TWYBITNHFBRGBG-UHFFFAOYSA-N 8,8-dimethyl-3-phenyl-6-(pyridin-2-ylmethoxy)-9,10-dihydro-7h-[1,2,4]triazolo[3,4-a]phthalazine Chemical compound C1C(C)(C)CCC(C2=NN=C(N2N=2)C=3C=CC=CC=3)=C1C=2OCC1=CC=CC=N1 TWYBITNHFBRGBG-UHFFFAOYSA-N 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- YRACHDVMKITFAZ-UHFFFAOYSA-N [1,2,4]triazolo[4,3-b]pyridazine Chemical class C1=CC=NN2C=NN=C21 YRACHDVMKITFAZ-UHFFFAOYSA-N 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 2
- 210000003169 central nervous system Anatomy 0.000 abstract description 2
- 125000005415 substituted alkoxy group Chemical group 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 270
- 238000000524 positive electrospray ionisation mass spectrometry Methods 0.000 description 246
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 235
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 195
- 101150041968 CDC13 gene Proteins 0.000 description 193
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 183
- 238000005160 1H NMR spectroscopy Methods 0.000 description 162
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 120
- 238000005481 NMR spectroscopy Methods 0.000 description 110
- 125000000217 alkyl group Chemical group 0.000 description 102
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 99
- SHNUBALDGXWUJI-UHFFFAOYSA-N pyridin-2-ylmethanol Chemical compound OCC1=CC=CC=N1 SHNUBALDGXWUJI-UHFFFAOYSA-N 0.000 description 95
- 239000000243 solution Substances 0.000 description 94
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 86
- 235000019439 ethyl acetate Nutrition 0.000 description 84
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 77
- 239000000047 product Substances 0.000 description 77
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 69
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 69
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 60
- 239000007787 solid Substances 0.000 description 55
- WEDYTSQNYJKOPC-UHFFFAOYSA-N (1-methyl-1,2,4-triazol-3-yl)methanol Chemical compound CN1C=NC(CO)=N1 WEDYTSQNYJKOPC-UHFFFAOYSA-N 0.000 description 52
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 51
- WARCRYXKINZHGQ-UHFFFAOYSA-N benzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1 WARCRYXKINZHGQ-UHFFFAOYSA-N 0.000 description 47
- QUAQZVSGXQVIEP-UHFFFAOYSA-N (2-methyl-1,2,4-triazol-3-yl)methanol Chemical compound CN1N=CN=C1CO QUAQZVSGXQVIEP-UHFFFAOYSA-N 0.000 description 43
- 239000000741 silica gel Substances 0.000 description 43
- 229910002027 silica gel Inorganic materials 0.000 description 43
- 229910052757 nitrogen Inorganic materials 0.000 description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 40
- 239000003921 oil Substances 0.000 description 38
- 235000019198 oils Nutrition 0.000 description 38
- 108091008681 GABAA receptors Proteins 0.000 description 37
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 36
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 35
- 102000027484 GABAA receptors Human genes 0.000 description 35
- 239000000284 extract Substances 0.000 description 34
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 32
- 238000006243 chemical reaction Methods 0.000 description 31
- 229910052938 sodium sulfate Inorganic materials 0.000 description 31
- 235000011152 sodium sulphate Nutrition 0.000 description 31
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 30
- 235000019341 magnesium sulphate Nutrition 0.000 description 30
- 239000007832 Na2SO4 Substances 0.000 description 29
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 28
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 28
- 239000012312 sodium hydride Substances 0.000 description 28
- 229910000104 sodium hydride Inorganic materials 0.000 description 28
- 239000011541 reaction mixture Substances 0.000 description 27
- 238000010992 reflux Methods 0.000 description 26
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 25
- 125000001424 substituent group Chemical group 0.000 description 25
- 238000004587 chromatography analysis Methods 0.000 description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 23
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 23
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 21
- 238000003818 flash chromatography Methods 0.000 description 21
- 239000010410 layer Substances 0.000 description 21
- 239000002904 solvent Substances 0.000 description 20
- 238000001914 filtration Methods 0.000 description 19
- 239000012044 organic layer Substances 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- JBDSSBMEKXHSJF-UHFFFAOYSA-N cyclopentanecarboxylic acid Chemical compound OC(=O)C1CCCC1 JBDSSBMEKXHSJF-UHFFFAOYSA-N 0.000 description 18
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical compound C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 18
- XSCHRSMBECNVNS-UHFFFAOYSA-N benzopyrazine Natural products N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 17
- 239000012267 brine Substances 0.000 description 17
- 239000006185 dispersion Substances 0.000 description 17
- 229920006395 saturated elastomer Polymers 0.000 description 17
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 17
- 125000003545 alkoxy group Chemical group 0.000 description 16
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 16
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 16
- QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 15
- 238000001816 cooling Methods 0.000 description 14
- VZFUCHSFHOYXIS-UHFFFAOYSA-N cycloheptane carboxylic acid Natural products OC(=O)C1CCCCCC1 VZFUCHSFHOYXIS-UHFFFAOYSA-N 0.000 description 14
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 14
- SOGBOGBTIKMGFS-UHFFFAOYSA-N thiophene-2-carbohydrazide Chemical compound NNC(=O)C1=CC=CS1 SOGBOGBTIKMGFS-UHFFFAOYSA-N 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 13
- 239000000460 chlorine Substances 0.000 description 13
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 13
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 13
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 12
- 239000003480 eluent Substances 0.000 description 12
- 229910052736 halogen Inorganic materials 0.000 description 12
- 150000002367 halogens Chemical class 0.000 description 12
- 229910003002 lithium salt Inorganic materials 0.000 description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 11
- ZECOOENHOVXEDD-UHFFFAOYSA-N 151813-29-5 Chemical compound C1CC2CCC1C1=C2C(=O)OC1=O ZECOOENHOVXEDD-UHFFFAOYSA-N 0.000 description 11
- 125000002757 morpholinyl group Chemical group 0.000 description 11
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 125000006513 pyridinyl methyl group Chemical group 0.000 description 10
- 238000010898 silica gel chromatography Methods 0.000 description 10
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 9
- 125000003282 alkyl amino group Chemical group 0.000 description 9
- 125000005843 halogen group Chemical group 0.000 description 9
- 238000000926 separation method Methods 0.000 description 9
- 235000017557 sodium bicarbonate Nutrition 0.000 description 9
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 9
- 239000008096 xylene Substances 0.000 description 9
- YJCCKQQVXNNAAR-UHFFFAOYSA-N 2-fluorobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1F YJCCKQQVXNNAAR-UHFFFAOYSA-N 0.000 description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 8
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 8
- 125000000753 cycloalkyl group Chemical group 0.000 description 8
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 8
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 8
- QNMBSXGYAQZCTN-UHFFFAOYSA-N thiophen-3-ylboronic acid Chemical compound OB(O)C=1C=CSC=1 QNMBSXGYAQZCTN-UHFFFAOYSA-N 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 102000005962 receptors Human genes 0.000 description 7
- 108020003175 receptors Proteins 0.000 description 7
- GCZGQVRHZLOCDD-UHFFFAOYSA-N 1-methylcyclobutane-1-carboxylic acid Chemical compound OC(=O)C1(C)CCC1 GCZGQVRHZLOCDD-UHFFFAOYSA-N 0.000 description 6
- MNIBBVOEXUQHFF-UHFFFAOYSA-N 1-methylcyclopentanecarboxylic acid Chemical compound OC(=O)C1(C)CCCC1 MNIBBVOEXUQHFF-UHFFFAOYSA-N 0.000 description 6
- REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical compound BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 6
- MFFVZXOPRXMVET-UHFFFAOYSA-N 4-methylbenzohydrazide Chemical compound CC1=CC=C(C(=O)NN)C=C1 MFFVZXOPRXMVET-UHFFFAOYSA-N 0.000 description 6
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 6
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
- 235000011054 acetic acid Nutrition 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- 239000012131 assay buffer Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 125000001309 chloro group Chemical group Cl* 0.000 description 6
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- 239000000543 intermediate Substances 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 125000003386 piperidinyl group Chemical group 0.000 description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 125000005302 thiazolylmethyl group Chemical group [H]C1=C([H])N=C(S1)C([H])([H])* 0.000 description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
- 125000004847 2-fluorobenzyl group Chemical group [H]C1=C([H])C(F)=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 5
- 239000000556 agonist Substances 0.000 description 5
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 238000000429 assembly Methods 0.000 description 5
- 230000000712 assembly Effects 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000012258 stirred mixture Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 5
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 5
- 239000003039 volatile agent Substances 0.000 description 5
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 4
- ACDAPUOXXWLLSC-UHFFFAOYSA-N (3-methylpyridin-2-yl)methanol Chemical compound CC1=CC=CN=C1CO ACDAPUOXXWLLSC-UHFFFAOYSA-N 0.000 description 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 4
- FGBCAURJSKHDGC-UHFFFAOYSA-N 2,4-difluorobenzohydrazide Chemical compound NNC(=O)C1=CC=C(F)C=C1F FGBCAURJSKHDGC-UHFFFAOYSA-N 0.000 description 4
- ROYHWGZNGMXQEU-UHFFFAOYSA-N 3,6-dichloro-4-methylpyridazine Chemical compound CC1=CC(Cl)=NN=C1Cl ROYHWGZNGMXQEU-UHFFFAOYSA-N 0.000 description 4
- BMASTHFFAMGJKZ-UHFFFAOYSA-N 4-bromo-1,2-dihydropyridazine-3,6-dione Chemical compound BrC1=CC(=O)NNC1=O BMASTHFFAMGJKZ-UHFFFAOYSA-N 0.000 description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- ZQKHRAXLCGDJDL-UHFFFAOYSA-N [1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]methanol Chemical compound C[Si](C)(C)CCOCN1C=CN=C1CO ZQKHRAXLCGDJDL-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 4
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 125000006431 methyl cyclopropyl group Chemical group 0.000 description 4
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 125000004193 piperazinyl group Chemical group 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 125000003373 pyrazinyl group Chemical group 0.000 description 4
- 125000002098 pyridazinyl group Chemical group 0.000 description 4
- 125000000714 pyrimidinyl group Chemical group 0.000 description 4
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 4
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 239000012279 sodium borohydride Substances 0.000 description 4
- 229910000033 sodium borohydride Inorganic materials 0.000 description 4
- 229910000029 sodium carbonate Inorganic materials 0.000 description 4
- 235000017550 sodium carbonate Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 235000011149 sulphuric acid Nutrition 0.000 description 4
- QSXOMCULJQCHDG-UHFFFAOYSA-N tert-butyl-dimethyl-[(3-methylimidazol-4-yl)methoxy]silane Chemical compound CN1C=NC=C1CO[Si](C)(C)C(C)(C)C QSXOMCULJQCHDG-UHFFFAOYSA-N 0.000 description 4
- ARYHTUPFQTUBBG-UHFFFAOYSA-N thiophen-2-ylboronic acid Chemical compound OB(O)C1=CC=CS1 ARYHTUPFQTUBBG-UHFFFAOYSA-N 0.000 description 4
- CILIDGFBNLYLMH-UHFFFAOYSA-N (4-chlorophthalazin-1-yl)hydrazine;hydrochloride Chemical compound Cl.C1=CC=C2C(NN)=NN=C(Cl)C2=C1 CILIDGFBNLYLMH-UHFFFAOYSA-N 0.000 description 3
- UTAFVZLZZYEYDA-UHFFFAOYSA-N 2-[[4-(furan-2-ylmethyl)-5-pyrazin-2-yl-1,2,4-triazol-3-yl]sulfanylmethyl]-1h-benzimidazole Chemical compound N=1C2=CC=CC=C2NC=1CSC(N1CC=2OC=CC=2)=NN=C1C1=CN=CC=N1 UTAFVZLZZYEYDA-UHFFFAOYSA-N 0.000 description 3
- FTIXDMFAYOIIQM-UHFFFAOYSA-N 3,6-dichloro-4-(furan-2-yl)pyridazine Chemical compound N1=NC(Cl)=CC(C=2OC=CC=2)=C1Cl FTIXDMFAYOIIQM-UHFFFAOYSA-N 0.000 description 3
- GUSWJGOYDXFJSI-UHFFFAOYSA-N 3,6-dichloropyridazine Chemical compound ClC1=CC=C(Cl)N=N1 GUSWJGOYDXFJSI-UHFFFAOYSA-N 0.000 description 3
- TWCGCUQPXQOQCA-UHFFFAOYSA-N 3-(chloromethyl)pyridazine Chemical compound ClCC1=CC=CN=N1 TWCGCUQPXQOQCA-UHFFFAOYSA-N 0.000 description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- SRXNAWZFFFRJJB-UHFFFAOYSA-N C=1C=CC=NC=1COC(C1=CC=NC=C1C1=NN=2)=NN1C=2C1=CC=CC=C1 Chemical compound C=1C=CC=NC=1COC(C1=CC=NC=C1C1=NN=2)=NN1C=2C1=CC=CC=C1 SRXNAWZFFFRJJB-UHFFFAOYSA-N 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 108090000543 Ligand-Gated Ion Channels Proteins 0.000 description 3
- 102000004086 Ligand-Gated Ion Channels Human genes 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 125000006402 chloropyridazinyl group Chemical group 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 125000002946 cyanobenzyl group Chemical group 0.000 description 3
- 125000004802 cyanophenyl group Chemical group 0.000 description 3
- TXWOGHSRPAYOML-UHFFFAOYSA-N cyclobutanecarboxylic acid Chemical compound OC(=O)C1CCC1 TXWOGHSRPAYOML-UHFFFAOYSA-N 0.000 description 3
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 3
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 3
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 3
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 3
- 229960004381 flumazenil Drugs 0.000 description 3
- SKTSVWWOAIAIKI-UHFFFAOYSA-N furan-2-carbohydrazide Chemical compound NNC(=O)C1=CC=CO1 SKTSVWWOAIAIKI-UHFFFAOYSA-N 0.000 description 3
- 239000012442 inert solvent Substances 0.000 description 3
- 230000009871 nonspecific binding Effects 0.000 description 3
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002953 preparative HPLC Methods 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- 239000000018 receptor agonist Substances 0.000 description 3
- 229940044601 receptor agonist Drugs 0.000 description 3
- 239000000377 silicon dioxide Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 239000001117 sulphuric acid Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- OCYGMRNKWAZEGT-UHFFFAOYSA-N tert-butyl-dimethyl-[(1-methylimidazol-4-yl)methoxy]silane Chemical compound CN1C=NC(CO[Si](C)(C)C(C)(C)C)=C1 OCYGMRNKWAZEGT-UHFFFAOYSA-N 0.000 description 3
- MJXVQODBCVNJOV-UHFFFAOYSA-N tert-butyl-dimethyl-[(2-propyl-1,2,4-triazol-3-yl)methoxy]silane Chemical compound CCCN1N=CN=C1CO[Si](C)(C)C(C)(C)C MJXVQODBCVNJOV-UHFFFAOYSA-N 0.000 description 3
- 125000001973 tert-pentyl group Chemical group [H]C([H])([H])C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 125000001425 triazolyl group Chemical group 0.000 description 3
- QYEQHVNOKQUFFM-UHFFFAOYSA-N (1-ethylimidazol-2-yl)methanol Chemical compound CCN1C=CN=C1CO QYEQHVNOKQUFFM-UHFFFAOYSA-N 0.000 description 2
- NLEAEGDBKRBJAP-UHFFFAOYSA-N (1-methylimidazol-4-yl)methanol Chemical compound CN1C=NC(CO)=C1 NLEAEGDBKRBJAP-UHFFFAOYSA-N 0.000 description 2
- VPUXNLAGWDWLEN-UHFFFAOYSA-N (1-propyl-1,2,4-triazol-3-yl)methanol Chemical compound CCCN1C=NC(CO)=N1 VPUXNLAGWDWLEN-UHFFFAOYSA-N 0.000 description 2
- PXGQMYCEAWZJJF-UHFFFAOYSA-N (3-methylimidazol-4-yl)methanol Chemical compound CN1C=NC=C1CO PXGQMYCEAWZJJF-UHFFFAOYSA-N 0.000 description 2
- DLLDJWMWMVUIDZ-UHFFFAOYSA-N (3-methyltriazol-4-yl)methanol Chemical compound CN1N=NC=C1CO DLLDJWMWMVUIDZ-UHFFFAOYSA-N 0.000 description 2
- CQMPPPAHJBQCOY-UHFFFAOYSA-N (4-methyl-1,3-thiazol-2-yl)methanol Chemical compound CC1=CSC(CO)=N1 CQMPPPAHJBQCOY-UHFFFAOYSA-N 0.000 description 2
- JFCLNCVCDFUJPO-UHFFFAOYSA-N (5-chlorothiophen-2-yl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)S1 JFCLNCVCDFUJPO-UHFFFAOYSA-N 0.000 description 2
- BWKAOFJDCPNWEC-UHFFFAOYSA-N (5-methyl-1,3-thiazol-2-yl)methanol Chemical compound CC1=CN=C(CO)S1 BWKAOFJDCPNWEC-UHFFFAOYSA-N 0.000 description 2
- SUXYJBSEDDEAMK-UHFFFAOYSA-N (6-chloro-5-morpholin-4-ylpyridazin-3-yl)hydrazine Chemical compound N1=NC(NN)=CC(N2CCOCC2)=C1Cl SUXYJBSEDDEAMK-UHFFFAOYSA-N 0.000 description 2
- WQVOUANKVCYEIQ-UHFFFAOYSA-N 1,3-thiazol-4-ylmethanol Chemical compound OCC1=CSC=N1 WQVOUANKVCYEIQ-UHFFFAOYSA-N 0.000 description 2
- NJRZMKZSODVWLS-UHFFFAOYSA-N 1,4-dichloro-6-methyl-5,6,7,8-tetrahydrophthalazine Chemical compound N1=NC(Cl)=C2CC(C)CCC2=C1Cl NJRZMKZSODVWLS-UHFFFAOYSA-N 0.000 description 2
- DIZKLZKLNKQFGB-UHFFFAOYSA-N 1-methylcyclopropane-1-carboxylic acid Chemical compound OC(=O)C1(C)CC1 DIZKLZKLNKQFGB-UHFFFAOYSA-N 0.000 description 2
- XXMFJKNOJSDQBM-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;hydrate Chemical compound [OH3+].[O-]C(=O)C(F)(F)F XXMFJKNOJSDQBM-UHFFFAOYSA-N 0.000 description 2
- SNTWKPAKVQFCCF-UHFFFAOYSA-N 2,3-dihydro-1h-triazole Chemical compound N1NC=CN1 SNTWKPAKVQFCCF-UHFFFAOYSA-N 0.000 description 2
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 2
- MSFVEEFXECBJPG-UHFFFAOYSA-N 2-(chloromethyl)pyrimidine Chemical compound ClCC1=NC=CC=N1 MSFVEEFXECBJPG-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- OHEFKPDASJTVDT-UHFFFAOYSA-N 3,6-dichloro-4-pyridin-4-ylpyridazine Chemical compound N1=NC(Cl)=CC(C=2C=CN=CC=2)=C1Cl OHEFKPDASJTVDT-UHFFFAOYSA-N 0.000 description 2
- IHCCAYCGZOLTEU-UHFFFAOYSA-N 3-furoic acid Chemical compound OC(=O)C=1C=COC=1 IHCCAYCGZOLTEU-UHFFFAOYSA-N 0.000 description 2
- HMMBJOWWRLZEMI-UHFFFAOYSA-N 4,5,6,7-tetrahydro-2-benzofuran-1,3-dione Chemical compound C1CCCC2=C1C(=O)OC2=O HMMBJOWWRLZEMI-UHFFFAOYSA-N 0.000 description 2
- WITWOVXHOBYYMU-UHFFFAOYSA-N 4-(3,6-dichloropyridazin-4-yl)morpholine Chemical compound N1=NC(Cl)=CC(N2CCOCC2)=C1Cl WITWOVXHOBYYMU-UHFFFAOYSA-N 0.000 description 2
- AROGQTWAAJTEFR-UHFFFAOYSA-N 4-(chloromethyl)pyrimidine Chemical compound ClCC1=CC=NC=N1 AROGQTWAAJTEFR-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- SWTIUJRWMYCKAI-UHFFFAOYSA-N 4-[3-bromo-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-[1,2,4]triazolo[4,3-b]pyridazin-7-yl]morpholine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(Br)N3N=2)N2CCOCC2)=N1 SWTIUJRWMYCKAI-UHFFFAOYSA-N 0.000 description 2
- UIVXXFYJRYVRKJ-UHFFFAOYSA-N 4-fluorobenzohydrazide Chemical compound NNC(=O)C1=CC=C(F)C=C1 UIVXXFYJRYVRKJ-UHFFFAOYSA-N 0.000 description 2
- BKAWJIRCKVUVED-UHFFFAOYSA-N 5-(2-hydroxyethyl)-4-methylthiazole Chemical compound CC=1N=CSC=1CCO BKAWJIRCKVUVED-UHFFFAOYSA-N 0.000 description 2
- PPPCEAMFCKQRHG-UHFFFAOYSA-N 5-(bromomethyl)pyrimidine Chemical compound BrCC1=CN=CN=C1 PPPCEAMFCKQRHG-UHFFFAOYSA-N 0.000 description 2
- VJHOEKXSWORTRP-UHFFFAOYSA-N 6-chloro-3-phenyl-7-piperidin-1-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound ClC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1N1CCCCC1 VJHOEKXSWORTRP-UHFFFAOYSA-N 0.000 description 2
- HNOGCUCCQQVHCI-UHFFFAOYSA-N 6-chloro-3-phenyl-[1,2,4]triazolo[3,4-a]phthalazine Chemical compound N=1N=C2C3=CC=CC=C3C(Cl)=NN2C=1C1=CC=CC=C1 HNOGCUCCQQVHCI-UHFFFAOYSA-N 0.000 description 2
- NXKGFOMUOFNBSO-UHFFFAOYSA-N 6-chloro-7-morpholin-4-yl-2h-[1,2,4]triazolo[4,3-b]pyridazin-3-one Chemical compound ClC1=NN(C(NN=2)=O)C=2C=C1N1CCOCC1 NXKGFOMUOFNBSO-UHFFFAOYSA-N 0.000 description 2
- JLVBSBMJQUMAMW-UHFFFAOYSA-N 6-methyl-2-pyridinemethanol Chemical compound CC1=CC=CC(CO)=N1 JLVBSBMJQUMAMW-UHFFFAOYSA-N 0.000 description 2
- MJMGXWLZSFFCEP-UHFFFAOYSA-N 6-methyl-5,6,7,8-tetrahydrophthalazine-1,4-dione Chemical compound O=C1N=NC(=O)C2=C1CC(C)CC2 MJMGXWLZSFFCEP-UHFFFAOYSA-N 0.000 description 2
- 208000008811 Agoraphobia Diseases 0.000 description 2
- 208000020925 Bipolar disease Diseases 0.000 description 2
- AKHHUNLXINLAAV-UHFFFAOYSA-N C=1C=CC=NC=1COC(C1=CN=CC=C1C1=NN=2)=NN1C=2C1=CC=CC=C1 Chemical compound C=1C=CC=NC=1COC(C1=CN=CC=C1C1=NN=2)=NN1C=2C1=CC=CC=C1 AKHHUNLXINLAAV-UHFFFAOYSA-N 0.000 description 2
- CYFVLJPAGXTDSG-UHFFFAOYSA-N C=1C=CC=NC=1COC(C=1CCNCC=1C1=NN=2)=NN1C=2C1=CC=CC=C1 Chemical compound C=1C=CC=NC=1COC(C=1CCNCC=1C1=NN=2)=NN1C=2C1=CC=CC=C1 CYFVLJPAGXTDSG-UHFFFAOYSA-N 0.000 description 2
- QHBMBQBPMXVQFL-UHFFFAOYSA-N C=1C=CC=NC=1COC(C=1CNCCC=1C1=NN=2)=NN1C=2C1=CC=CC=C1 Chemical compound C=1C=CC=NC=1COC(C=1CNCCC=1C1=NN=2)=NN1C=2C1=CC=CC=C1 QHBMBQBPMXVQFL-UHFFFAOYSA-N 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- PPTYJKAXVCCBDU-UHFFFAOYSA-N Rohypnol Chemical compound N=1CC(=O)N(C)C2=CC=C([N+]([O-])=O)C=C2C=1C1=CC=CC=C1F PPTYJKAXVCCBDU-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 2
- KLPVTNQTQDEAAU-UHFFFAOYSA-N [3-(cyclopropylmethoxy)pyridin-2-yl]methanol Chemical compound OCC1=NC=CC=C1OCC1CC1 KLPVTNQTQDEAAU-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- AEILLAXRDHDKDY-UHFFFAOYSA-N bromomethylcyclopropane Chemical compound BrCC1CC1 AEILLAXRDHDKDY-UHFFFAOYSA-N 0.000 description 2
- 230000005587 bubbling Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 125000001162 cycloheptenyl group Chemical group C1(=CCCCCC1)* 0.000 description 2
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 2
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 2
- SMBQBQBNOXIFSF-UHFFFAOYSA-N dilithium Chemical class [Li][Li] SMBQBQBNOXIFSF-UHFFFAOYSA-N 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000012055 enteric layer Substances 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229960002200 flunitrazepam Drugs 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 125000001207 fluorophenyl group Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 150000002429 hydrazines Chemical class 0.000 description 2
- 150000002431 hydrogen Chemical group 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000005567 liquid scintillation counting Methods 0.000 description 2
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 2
- 125000002524 organometallic group Chemical group 0.000 description 2
- 208000019906 panic disease Diseases 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- LFCWHDGQCWJKCG-UHFFFAOYSA-N pyrazin-2-ylmethanol Chemical compound OCC1=CN=CC=N1 LFCWHDGQCWJKCG-UHFFFAOYSA-N 0.000 description 2
- KFUSANSHCADHNJ-UHFFFAOYSA-N pyridine-3-carbohydrazide Chemical compound NNC(=O)C1=CC=CN=C1 KFUSANSHCADHNJ-UHFFFAOYSA-N 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 239000002287 radioligand Substances 0.000 description 2
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 229960001367 tartaric acid Drugs 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- BDFQZWRQGDNIOX-UHFFFAOYSA-N tert-butyl 5-phenyl-8-(pyridin-2-ylmethoxy)-3,4,6,7,11-pentazatricyclo[7.4.0.02,6]trideca-1(9),2,4,7-tetraene-11-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCC(C2=NN=C(N2N=2)C=3C=CC=CC=3)=C1C=2OCC1=CC=CC=N1 BDFQZWRQGDNIOX-UHFFFAOYSA-N 0.000 description 2
- QAXFVMVLPQLYGL-UHFFFAOYSA-N tert-butyl 5-phenyl-8-(pyridin-2-ylmethoxy)-3,4,6,7,12-pentazatricyclo[7.4.0.02,6]trideca-1(9),2,4,7-tetraene-12-carboxylate Chemical compound N=1N2C(C=3C=CC=CC=3)=NN=C2C=2CN(C(=O)OC(C)(C)C)CCC=2C=1OCC1=CC=CC=N1 QAXFVMVLPQLYGL-UHFFFAOYSA-N 0.000 description 2
- FQFILJKFZCVHNH-UHFFFAOYSA-N tert-butyl n-[3-[(5-bromo-2-chloropyrimidin-4-yl)amino]propyl]carbamate Chemical compound CC(C)(C)OC(=O)NCCCNC1=NC(Cl)=NC=C1Br FQFILJKFZCVHNH-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- GRGCWBWNLSTIEN-UHFFFAOYSA-N trifluoromethanesulfonyl chloride Chemical compound FC(F)(F)S(Cl)(=O)=O GRGCWBWNLSTIEN-UHFFFAOYSA-N 0.000 description 2
- SGIKRGDBBXWNRI-UHFFFAOYSA-N (1-benzylimidazol-2-yl)methanol Chemical compound OCC1=NC=CN1CC1=CC=CC=C1 SGIKRGDBBXWNRI-UHFFFAOYSA-N 0.000 description 1
- CDQDMLWGTVLQEE-UHFFFAOYSA-N (1-methylimidazol-2-yl)methanol Chemical compound CN1C=CN=C1CO CDQDMLWGTVLQEE-UHFFFAOYSA-N 0.000 description 1
- OUXGHJCAIAMWRQ-UHFFFAOYSA-N (2-propyl-1,2,4-triazol-3-yl)methanol Chemical compound CCCN1N=CN=C1CO OUXGHJCAIAMWRQ-UHFFFAOYSA-N 0.000 description 1
- CMIBUZBMZCBCAT-HZPDHXFCSA-N (2r,3r)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid Chemical compound C1=CC(C)=CC=C1C(=O)O[C@@H](C(O)=O)[C@H](C(O)=O)OC(=O)C1=CC=C(C)C=C1 CMIBUZBMZCBCAT-HZPDHXFCSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- OBENDWOJIFFDLZ-UHFFFAOYSA-N (3,5-dimethylpyrazol-1-yl)methanol Chemical compound CC=1C=C(C)N(CO)N=1 OBENDWOJIFFDLZ-UHFFFAOYSA-N 0.000 description 1
- BBUQQGMZGGFKDP-UHFFFAOYSA-N (3,5-dimethylpyridin-2-yl)methanol Chemical compound CC1=CN=C(CO)C(C)=C1 BBUQQGMZGGFKDP-UHFFFAOYSA-N 0.000 description 1
- QLAGECZOQRFYJG-UHFFFAOYSA-N (3-ethoxypyridin-2-yl)methanol Chemical compound CCOC1=CC=CN=C1CO QLAGECZOQRFYJG-UHFFFAOYSA-N 0.000 description 1
- KNXQDJCZSVHEIW-UHFFFAOYSA-N (3-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(F)=C1 KNXQDJCZSVHEIW-UHFFFAOYSA-N 0.000 description 1
- MWWCRZWOTAOLEX-UHFFFAOYSA-N (3-methylpyridin-4-yl)methanol Chemical compound CC1=CN=CC=C1CO MWWCRZWOTAOLEX-UHFFFAOYSA-N 0.000 description 1
- KMOUUZVZFBCRAM-OLQVQODUSA-N (3as,7ar)-3a,4,7,7a-tetrahydro-2-benzofuran-1,3-dione Chemical compound C1C=CC[C@@H]2C(=O)OC(=O)[C@@H]21 KMOUUZVZFBCRAM-OLQVQODUSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical group CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- VKQZCYMDNLIADD-UHFFFAOYSA-N (4,6-dimethylpyridin-2-yl)methanol Chemical compound CC1=CC(C)=NC(CO)=C1 VKQZCYMDNLIADD-UHFFFAOYSA-N 0.000 description 1
- ZBLLDDHCACSORX-UHFFFAOYSA-N (4-chloro-5,6,7,8-tetrahydrophthalazin-1-yl)hydrazine Chemical compound C1CCCC2=C1C(Cl)=NN=C2NN ZBLLDDHCACSORX-UHFFFAOYSA-N 0.000 description 1
- MTYDTSHOQKECQS-UHFFFAOYSA-N (4-methylpyridin-2-yl)methanol Chemical compound CC1=CC=NC(CO)=C1 MTYDTSHOQKECQS-UHFFFAOYSA-N 0.000 description 1
- AFQXZHJUNVABML-UHFFFAOYSA-N (5,6-dimethylpyridin-2-yl)methanol Chemical compound CC1=CC=C(CO)N=C1C AFQXZHJUNVABML-UHFFFAOYSA-N 0.000 description 1
- MDYHWQQHEWDJKR-UHFFFAOYSA-N (5-methyl-1,2-oxazol-3-yl)methanol Chemical compound CC1=CC(CO)=NO1 MDYHWQQHEWDJKR-UHFFFAOYSA-N 0.000 description 1
- HYOBIUULDPLKIE-UHFFFAOYSA-N (5-methylpyridin-2-yl)methanol Chemical compound CC1=CC=C(CO)N=C1 HYOBIUULDPLKIE-UHFFFAOYSA-N 0.000 description 1
- SHJXFWOLVQSHRF-UHFFFAOYSA-N (6-methylpyridin-2-yl)methanol;(6-methylpyridin-2-yl)methyl acetate Chemical compound CC1=CC=CC(CO)=N1.CC(=O)OCC1=CC=CC(C)=N1 SHJXFWOLVQSHRF-UHFFFAOYSA-N 0.000 description 1
- ZRNXOHYTSIFSDP-UHFFFAOYSA-N (6-methylpyridin-2-yl)methyl acetate Chemical compound CC(=O)OCC1=CC=CC(C)=N1 ZRNXOHYTSIFSDP-UHFFFAOYSA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- 125000001414 1,2,4-triazol-5-yl group Chemical class [H]N1N=C([H])N=C1[*] 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- YRIZYWQGELRKNT-UHFFFAOYSA-N 1,3,5-trichloro-1,3,5-triazinane-2,4,6-trione Chemical compound ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O YRIZYWQGELRKNT-UHFFFAOYSA-N 0.000 description 1
- JNHDLNXNYPLBMJ-UHFFFAOYSA-N 1,3-thiazol-2-ylmethanol Chemical compound OCC1=NC=CS1 JNHDLNXNYPLBMJ-UHFFFAOYSA-N 0.000 description 1
- KLFNXIXNWZZRLE-UHFFFAOYSA-N 1,4-dichloro-5,6,7,8-tetrahydrophthalazine Chemical compound C1CCCC2=C1C(Cl)=NN=C2Cl KLFNXIXNWZZRLE-UHFFFAOYSA-N 0.000 description 1
- VRPPBGTUTNCVED-UHFFFAOYSA-N 1,4-dichloro-7,7-dimethyl-6,8-dihydro-5h-phthalazine Chemical compound N1=NC(Cl)=C2CC(C)(C)CCC2=C1Cl VRPPBGTUTNCVED-UHFFFAOYSA-N 0.000 description 1
- RCHDLEVSZBOHOS-UHFFFAOYSA-N 1,4-dichlorobut-2-yne Chemical compound ClCC#CCCl RCHDLEVSZBOHOS-UHFFFAOYSA-N 0.000 description 1
- ODCNAEMHGMYADO-UHFFFAOYSA-N 1,4-dichlorophthalazine Chemical compound C1=CC=C2C(Cl)=NN=C(Cl)C2=C1 ODCNAEMHGMYADO-UHFFFAOYSA-N 0.000 description 1
- ZPIHRUCXNRKJIF-UHFFFAOYSA-N 1-(2-trimethylsilylethoxymethyl)imidazole-2-carbaldehyde Chemical compound C[Si](C)(C)CCOCN1C=CN=C1C=O ZPIHRUCXNRKJIF-UHFFFAOYSA-N 0.000 description 1
- LSNWNTHKHQTQMT-UHFFFAOYSA-N 1-(chloromethyl)isoquinoline Chemical compound C1=CC=C2C(CCl)=NC=CC2=C1 LSNWNTHKHQTQMT-UHFFFAOYSA-N 0.000 description 1
- HNIHOFVDKWEICB-UHFFFAOYSA-N 1-fluorocyclobutane-1-carboxylic acid Chemical compound OC(=O)C1(F)CCC1 HNIHOFVDKWEICB-UHFFFAOYSA-N 0.000 description 1
- BAUWRHPMUVYFOD-UHFFFAOYSA-N 1-methylpiperidin-4-ol Chemical compound CN1CCC(O)CC1 BAUWRHPMUVYFOD-UHFFFAOYSA-N 0.000 description 1
- JWAWEQBUZOGIBZ-UHFFFAOYSA-N 1-methyltriazole Chemical compound CN1C=CN=N1 JWAWEQBUZOGIBZ-UHFFFAOYSA-N 0.000 description 1
- VVNKQEJVCBMGHV-UHFFFAOYSA-N 19479-86-8 Chemical compound C1C2CCC1C1=C2C(=O)OC1=O VVNKQEJVCBMGHV-UHFFFAOYSA-N 0.000 description 1
- IAJLTMBBAVVMQO-UHFFFAOYSA-N 1h-benzimidazol-2-ylmethanol Chemical compound C1=CC=C2NC(CO)=NC2=C1 IAJLTMBBAVVMQO-UHFFFAOYSA-N 0.000 description 1
- VUAXHMVRKOTJKP-UHFFFAOYSA-N 2,2-dimethylbutyric acid Chemical compound CCC(C)(C)C(O)=O VUAXHMVRKOTJKP-UHFFFAOYSA-N 0.000 description 1
- SYOANZBNGDEJFH-UHFFFAOYSA-N 2,5-dihydro-1h-triazole Chemical compound C1NNN=C1 SYOANZBNGDEJFH-UHFFFAOYSA-N 0.000 description 1
- LIDGFHXPUOJZMK-UHFFFAOYSA-N 2,6-dimethyl-1-oxidopyridin-1-ium Chemical compound CC1=CC=CC(C)=[N+]1[O-] LIDGFHXPUOJZMK-UHFFFAOYSA-N 0.000 description 1
- GFHPSQFCHUIFTO-UHFFFAOYSA-N 2-(chloromethyl)pyrazine Chemical compound ClCC1=CN=CC=N1 GFHPSQFCHUIFTO-UHFFFAOYSA-N 0.000 description 1
- NJWIMFZLESWFIM-UHFFFAOYSA-N 2-(chloromethyl)pyridine Chemical compound ClCC1=CC=CC=N1 NJWIMFZLESWFIM-UHFFFAOYSA-N 0.000 description 1
- WDRBAGBHWTUWCE-UHFFFAOYSA-N 2-(chloromethyl)pyrimidine;1,3,5-trichloro-1,3,5-triazinane-2,4,6-trione Chemical compound ClCC1=NC=CC=N1.ClN1C(=O)N(Cl)C(=O)N(Cl)C1=O WDRBAGBHWTUWCE-UHFFFAOYSA-N 0.000 description 1
- DDEAEWMDOSXKBX-UHFFFAOYSA-N 2-(chloromethyl)quinoline Chemical compound C1=CC=CC2=NC(CCl)=CC=C21 DDEAEWMDOSXKBX-UHFFFAOYSA-N 0.000 description 1
- AAUVNJJBLOZTAO-UHFFFAOYSA-N 2-(chloromethyl)quinoxaline Chemical compound C1=CC=CC2=NC(CCl)=CN=C21 AAUVNJJBLOZTAO-UHFFFAOYSA-N 0.000 description 1
- 125000003821 2-(trimethylsilyl)ethoxymethyl group Chemical group [H]C([H])([H])[Si](C([H])([H])[H])(C([H])([H])[H])C([H])([H])C(OC([H])([H])[*])([H])[H] 0.000 description 1
- MIVUDAUOXJDARR-UHFFFAOYSA-N 2-[(3,5-dinitrobenzoyl)amino]-2-phenylacetic acid Chemical compound C=1C=CC=CC=1C(C(=O)O)NC(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 MIVUDAUOXJDARR-UHFFFAOYSA-N 0.000 description 1
- PGFIHORVILKHIA-UHFFFAOYSA-N 2-bromopyrimidine Chemical compound BrC1=NC=CC=N1 PGFIHORVILKHIA-UHFFFAOYSA-N 0.000 description 1
- AAOSLLBWWRKJIR-UHFFFAOYSA-N 2-chloro-1-pyrrolidin-1-ylethanone Chemical compound ClCC(=O)N1CCCC1 AAOSLLBWWRKJIR-UHFFFAOYSA-N 0.000 description 1
- LNJMHEJAYSYZKK-UHFFFAOYSA-N 2-methylpyrimidine Chemical compound CC1=NC=CC=N1 LNJMHEJAYSYZKK-UHFFFAOYSA-N 0.000 description 1
- RGHPCLZJAFCTIK-UHFFFAOYSA-N 2-methylpyrrolidine Chemical compound CC1CCCN1 RGHPCLZJAFCTIK-UHFFFAOYSA-N 0.000 description 1
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 1
- SGTXILTYXULEQD-UHFFFAOYSA-N 2H-triazolo[4,5-f]phthalazine Chemical group N1=NC=C2C3=NNN=C3C=CC2=C1 SGTXILTYXULEQD-UHFFFAOYSA-N 0.000 description 1
- RUVVGCRPPJVNMC-UHFFFAOYSA-N 3,6-dichloro-4,5-dimethylpyridazine Chemical compound CC1=C(C)C(Cl)=NN=C1Cl RUVVGCRPPJVNMC-UHFFFAOYSA-N 0.000 description 1
- YYESFGLDKLTUCO-UHFFFAOYSA-N 3,6-dichloro-4-cyclopentylpyridazine Chemical compound N1=NC(Cl)=CC(C2CCCC2)=C1Cl YYESFGLDKLTUCO-UHFFFAOYSA-N 0.000 description 1
- JGSDXYKPYCBWRI-UHFFFAOYSA-N 3,6-dichloro-4-piperidin-1-ylpyridazine Chemical compound N1=NC(Cl)=CC(N2CCCCC2)=C1Cl JGSDXYKPYCBWRI-UHFFFAOYSA-N 0.000 description 1
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- AJKPWFIRLCHFCQ-UHFFFAOYSA-N 3,7-diphenyl-5h-[1,2,4]triazolo[4,3-b]pyridazin-6-one Chemical compound O=C1NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 AJKPWFIRLCHFCQ-UHFFFAOYSA-N 0.000 description 1
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical group C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- QRVATIMYRMQIKG-UHFFFAOYSA-N 3-(furan-3-yl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C2=COC=C2)C=2C=CC=CC=2)=N1 QRVATIMYRMQIKG-UHFFFAOYSA-N 0.000 description 1
- YPRMWCKXOZFJGF-UHFFFAOYSA-N 3-bromofuran-2,5-dione Chemical compound BrC1=CC(=O)OC1=O YPRMWCKXOZFJGF-UHFFFAOYSA-N 0.000 description 1
- XWFUSBPVIYJBML-UHFFFAOYSA-N 3-chloro-6-(chloromethyl)pyridazine Chemical compound ClCC1=CC=C(Cl)N=N1 XWFUSBPVIYJBML-UHFFFAOYSA-N 0.000 description 1
- AXGOOCLYBPQWNG-UHFFFAOYSA-N 3-ethylfuran-2,5-dione Chemical compound CCC1=CC(=O)OC1=O AXGOOCLYBPQWNG-UHFFFAOYSA-N 0.000 description 1
- 125000006284 3-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C(F)=C1[H])C([H])([H])* 0.000 description 1
- VMZSDAQEWPNOIB-UHFFFAOYSA-N 3-methoxybenzohydrazide Chemical compound COC1=CC=CC(C(=O)NN)=C1 VMZSDAQEWPNOIB-UHFFFAOYSA-N 0.000 description 1
- QZYCWJVSPFQUQC-UHFFFAOYSA-N 3-phenylfuran-2,5-dione Chemical compound O=C1OC(=O)C(C=2C=CC=CC=2)=C1 QZYCWJVSPFQUQC-UHFFFAOYSA-N 0.000 description 1
- MVQVNTPHUGQQHK-UHFFFAOYSA-N 3-pyridinemethanol Chemical compound OCC1=CC=CN=C1 MVQVNTPHUGQQHK-UHFFFAOYSA-N 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- LBXZLFZVTDYSIZ-UHFFFAOYSA-N 4-(3-bromo-6-chloro-[1,2,4]triazolo[4,3-b]pyridazin-7-yl)morpholine Chemical compound ClC1=NN2C(Br)=NN=C2C=C1N1CCOCC1 LBXZLFZVTDYSIZ-UHFFFAOYSA-N 0.000 description 1
- CRZPXVXJMFQSOL-UHFFFAOYSA-N 4-(chloromethyl)-2-ethyl-1,3-thiazole Chemical compound CCC1=NC(CCl)=CS1 CRZPXVXJMFQSOL-UHFFFAOYSA-N 0.000 description 1
- AQBBZYVPKBIILN-UHFFFAOYSA-N 4-(chloromethyl)-2-methyl-1,3-thiazole Chemical compound CC1=NC(CCl)=CS1 AQBBZYVPKBIILN-UHFFFAOYSA-N 0.000 description 1
- XAXKZIUQIROVNV-UHFFFAOYSA-N 4-bromo-3,6-dichloropyridazine Chemical compound ClC1=CC(Br)=C(Cl)N=N1 XAXKZIUQIROVNV-UHFFFAOYSA-N 0.000 description 1
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 description 1
- REKQLYUAUXYJSZ-UHFFFAOYSA-N 4-methoxybenzohydrazide Chemical compound COC1=CC=C(C(=O)NN)C=C1 REKQLYUAUXYJSZ-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- WJHYLPADRKEKNI-UHFFFAOYSA-N 4-methylcyclohexene-1,2-dicarboxylic acid Chemical compound CC1CCC(C(O)=O)=C(C(O)=O)C1 WJHYLPADRKEKNI-UHFFFAOYSA-N 0.000 description 1
- WWGMZBKFJMEQLG-UHFFFAOYSA-N 4-oxatricyclo[5.3.2.02,6]dodec-2(6)-ene-3,5-dione Chemical compound C1CCC2CCC1C1=C2C(=O)OC1=O WWGMZBKFJMEQLG-UHFFFAOYSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- CVNJOSWQRUPTGE-UHFFFAOYSA-N 5,6,7,8-tetrahydro-4h-cyclohepta[c]furan-1,3-dione Chemical compound C1CCCCC2=C1C(=O)OC2=O CVNJOSWQRUPTGE-UHFFFAOYSA-N 0.000 description 1
- YGFXNNJIVZUYCL-UHFFFAOYSA-N 5-(chloromethyl)-2-methyltetrazole Chemical compound CN1N=NC(CCl)=N1 YGFXNNJIVZUYCL-UHFFFAOYSA-N 0.000 description 1
- FYDQQEVRVKAASZ-UHFFFAOYSA-N 5-(chloromethyl)-3-methyl-1,2,4-oxadiazole Chemical compound CC1=NOC(CCl)=N1 FYDQQEVRVKAASZ-UHFFFAOYSA-N 0.000 description 1
- HCQUWYYALIXUBW-UHFFFAOYSA-N 5-(dibromomethyl)pyrimidine Chemical compound BrC(Br)C1=CN=CN=C1 HCQUWYYALIXUBW-UHFFFAOYSA-N 0.000 description 1
- GZXDOXSIKJNUEW-UHFFFAOYSA-N 5-methylthiophene Chemical compound CC1=C=C[CH]S1 GZXDOXSIKJNUEW-UHFFFAOYSA-N 0.000 description 1
- SHGCXQYBDSEUSK-UHFFFAOYSA-N 6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-7-phenyl-3-thiophen-2-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C=2C=CC=CC=2)=NN2C1=NN=C2C1=CC=CS1 SHGCXQYBDSEUSK-UHFFFAOYSA-N 0.000 description 1
- XSEMGHQIUGDUIY-UHFFFAOYSA-N 6-[(2-methyltriazol-4-yl)methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C=2C=CC=CC=2)=N1 XSEMGHQIUGDUIY-UHFFFAOYSA-N 0.000 description 1
- JEHGFXFTLUHABO-UHFFFAOYSA-N 6-chloro-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound ClC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=CC=C1 JEHGFXFTLUHABO-UHFFFAOYSA-N 0.000 description 1
- CCURZJJCGOTOBM-UHFFFAOYSA-N 6-chloro-3-phenyl-7-pyridin-4-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound ClC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1=CC=NC=C1 CCURZJJCGOTOBM-UHFFFAOYSA-N 0.000 description 1
- QCGHVFASTYYJNT-UHFFFAOYSA-N 6-chloro-3-phenyl-7-pyrrolidin-1-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound ClC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1N1CCCC1 QCGHVFASTYYJNT-UHFFFAOYSA-N 0.000 description 1
- VOCMNGMXRYQFJN-UHFFFAOYSA-N 6-chloro-7-(1-methylcyclopentyl)-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C=1C2=NN=C(C=3C=CC=CC=3)N2N=C(Cl)C=1C1(C)CCCC1 VOCMNGMXRYQFJN-UHFFFAOYSA-N 0.000 description 1
- KHTBOHFYNQGICR-UHFFFAOYSA-N 6-chloro-7-cyclobutyl-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound ClC1=NN2C(C=3C=CC=CC=3)=NN=C2C=C1C1CCC1 KHTBOHFYNQGICR-UHFFFAOYSA-N 0.000 description 1
- VPEZBSPBZSWTGR-UHFFFAOYSA-N 6-chloro-7-cyclopentyl-3-thiophen-2-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound ClC1=NN2C(C=3SC=CC=3)=NN=C2C=C1C1CCCC1 VPEZBSPBZSWTGR-UHFFFAOYSA-N 0.000 description 1
- MDUDQSYGSILSJB-UHFFFAOYSA-N 6-chloro-n,n-diethyl-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-7-amine Chemical compound N12N=C(Cl)C(N(CC)CC)=CC2=NN=C1C1=CC=CC=C1 MDUDQSYGSILSJB-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- YMQOGAWQHTZWAL-UHFFFAOYSA-N 7-(1-methylcyclopropyl)-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1N=CN=C1COC(C(=C1)C2(C)CC2)=NN2C1=NN=C2C1=CC=CC=C1 YMQOGAWQHTZWAL-UHFFFAOYSA-N 0.000 description 1
- RZMOWUBQZJZECS-UHFFFAOYSA-N 7-(furan-3-yl)-6-[(1-methyl-1,2,4-triazol-3-yl)methoxy]-3-phenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound CN1C=NC(COC=2C(=CC3=NN=C(N3N=2)C=2C=CC=CC=2)C2=COC=C2)=N1 RZMOWUBQZJZECS-UHFFFAOYSA-N 0.000 description 1
- BJEUFRRYFHTBDI-UHFFFAOYSA-N 7-pyrrolidin-1-yl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound C1CCCN1C1=CC2=NN=CN2N=C1 BJEUFRRYFHTBDI-UHFFFAOYSA-N 0.000 description 1
- XQFGDFHDKHDYQZ-UHFFFAOYSA-N 8-methyl-6-[(2-methyl-1,2,4-triazol-3-yl)methoxy]-3,7-diphenyl-[1,2,4]triazolo[4,3-b]pyridazine Chemical compound N=1N2C(C=3C=CC=CC=3)=NN=C2C(C)=C(C=2C=CC=CC=2)C=1OCC1=NC=NN1C XQFGDFHDKHDYQZ-UHFFFAOYSA-N 0.000 description 1
- JRLTTZUODKEYDH-UHFFFAOYSA-N 8-methylquinoline Chemical group C1=CN=C2C(C)=CC=CC2=C1 JRLTTZUODKEYDH-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- IVRMZWNICZWHMI-UHFFFAOYSA-N Azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- ICRVOGPNDJEETR-UHFFFAOYSA-N C1N(C)CCC(C2=NN=C(N2N=2)C=3C=CC=CC=3)=C1C=2OCC1=CC=CC=N1 Chemical compound C1N(C)CCC(C2=NN=C(N2N=2)C=3C=CC=CC=3)=C1C=2OCC1=CC=CC=N1 ICRVOGPNDJEETR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 238000003820 Medium-pressure liquid chromatography Methods 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 241000206607 Porphyra umbilicalis Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010041250 Social phobia Diseases 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000013200 Stress disease Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- SEQDDYPDSLOBDC-UHFFFAOYSA-N Temazepam Chemical compound N=1C(O)C(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 SEQDDYPDSLOBDC-UHFFFAOYSA-N 0.000 description 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 208000031674 Traumatic Acute Stress disease Diseases 0.000 description 1
- JVJPJKLSGUJUJK-UHFFFAOYSA-N [1,2,4]triazolo[3,4-a]phthalazine Chemical class C1=CC=C2C=NN3C=NN=C3C2=C1 JVJPJKLSGUJUJK-UHFFFAOYSA-N 0.000 description 1
- KMXANNVLSSYIHB-UHFFFAOYSA-N [2-(2-trimethylsilylethoxymethyl)-1,2,4-triazol-3-yl]methanol Chemical compound C[Si](C)(C)CCOCN1N=CN=C1CO KMXANNVLSSYIHB-UHFFFAOYSA-N 0.000 description 1
- YWMLORGQOFONNT-UHFFFAOYSA-N [3-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=CC(CO)=C1 YWMLORGQOFONNT-UHFFFAOYSA-N 0.000 description 1
- YIMQCDZDWXUDCA-UHFFFAOYSA-N [4-(hydroxymethyl)cyclohexyl]methanol Chemical compound OCC1CCC(CO)CC1 YIMQCDZDWXUDCA-UHFFFAOYSA-N 0.000 description 1
- XCDLMXUNXHXCAG-UHFFFAOYSA-N [5-methyl-1-(2-trimethylsilylethoxymethyl)imidazol-2-yl]methanol Chemical compound CC1=CN=C(CO)N1COCC[Si](C)(C)C XCDLMXUNXHXCAG-UHFFFAOYSA-N 0.000 description 1
- QRZPWHITTFPBEO-UHFFFAOYSA-N [5-methyl-2-(2-trimethylsilylethoxy)-1,2,4-triazol-3-yl]methanol Chemical compound OCC=1N(N=C(N=1)C)OCC[Si](C)(C)C QRZPWHITTFPBEO-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- OFLXLNCGODUUOT-UHFFFAOYSA-N acetohydrazide Chemical compound C\C(O)=N\N OFLXLNCGODUUOT-UHFFFAOYSA-N 0.000 description 1
- OMUBQVJUZLNSDL-UHFFFAOYSA-N acetyl acetate;(6-methylpyridin-2-yl)methyl acetate Chemical compound CC(=O)OC(C)=O.CC(=O)OCC1=CC=CC(C)=N1 OMUBQVJUZLNSDL-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000026345 acute stress disease Diseases 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- XCSGPAVHZFQHGE-UHFFFAOYSA-N alachlor Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl XCSGPAVHZFQHGE-UHFFFAOYSA-N 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- JRTIDHTUMYMPRU-UHFFFAOYSA-N alpidem Chemical compound N1=C2C=CC(Cl)=CN2C(CC(=O)N(CCC)CCC)=C1C1=CC=C(Cl)C=C1 JRTIDHTUMYMPRU-UHFFFAOYSA-N 0.000 description 1
- 229950008673 alpidem Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 229940090047 auto-injector Drugs 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- AZWXAPCAJCYGIA-UHFFFAOYSA-N bis(2-methylpropyl)alumane Chemical compound CC(C)C[AlH]CC(C)C AZWXAPCAJCYGIA-UHFFFAOYSA-N 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000005100 correlation spectroscopy Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 125000000000 cycloalkoxy group Chemical group 0.000 description 1
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 1
- 125000004090 cyclononenyl group Chemical group C1(=CCCCCCCC1)* 0.000 description 1
- 125000000522 cyclooctenyl group Chemical group C1(=CCCCCCC1)* 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- JFYKIEHOOZWARC-UHFFFAOYSA-N cyclopropanecarbohydrazide Chemical compound NNC(=O)C1CC1 JFYKIEHOOZWARC-UHFFFAOYSA-N 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 208000026725 cyclothymic disease Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 1
- 125000004987 dibenzofuryl group Chemical group C1(=CC=CC=2OC3=C(C21)C=CC=C3)* 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000004212 difluorophenyl group Chemical group 0.000 description 1
- 125000005046 dihydronaphthyl group Chemical group 0.000 description 1
- SIPUZPBQZHNSDW-UHFFFAOYSA-N diisobutylaluminium hydride Substances CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 1
- UBEKYGUUQKFFTI-UHFFFAOYSA-N dimethyl 2-pyrimidin-2-ylpropanedioate Chemical compound COC(=O)C(C(=O)OC)C1=NC=CC=N1 UBEKYGUUQKFFTI-UHFFFAOYSA-N 0.000 description 1
- PBPNQNBSWCQVSV-UHFFFAOYSA-N dimethyl 2-pyrimidin-2-ylpropanedioate;2-methylpyrimidine Chemical compound CC1=NC=CC=N1.COC(=O)C(C(=O)OC)C1=NC=CC=N1 PBPNQNBSWCQVSV-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- BEPAFCGSDWSTEL-UHFFFAOYSA-N dimethyl malonate Chemical compound COC(=O)CC(=O)OC BEPAFCGSDWSTEL-UHFFFAOYSA-N 0.000 description 1
- UZUODNWWWUQRIR-UHFFFAOYSA-L disodium;3-aminonaphthalene-1,5-disulfonate Chemical compound [Na+].[Na+].C1=CC=C(S([O-])(=O)=O)C2=CC(N)=CC(S([O-])(=O)=O)=C21 UZUODNWWWUQRIR-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 208000024732 dysthymic disease Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- XBRDBODLCHKXHI-UHFFFAOYSA-N epolamine Chemical compound OCCN1CCCC1 XBRDBODLCHKXHI-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- VFRSADQPWYCXDG-LEUCUCNGSA-N ethyl (2s,5s)-5-methylpyrrolidine-2-carboxylate;2,2,2-trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.CCOC(=O)[C@@H]1CC[C@H](C)N1 VFRSADQPWYCXDG-LEUCUCNGSA-N 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000020375 flavoured syrup Nutrition 0.000 description 1
- OFBIFZUFASYYRE-UHFFFAOYSA-N flumazenil Chemical compound C1N(C)C(=O)C2=CC(F)=CC=C2N2C=NC(C(=O)OCC)=C21 OFBIFZUFASYYRE-UHFFFAOYSA-N 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- CYEFKCRAAGLNHW-UHFFFAOYSA-N furan-3-ylboronic acid Chemical compound OB(O)C=1C=COC=1 CYEFKCRAAGLNHW-UHFFFAOYSA-N 0.000 description 1
- KFKMGUPDWTWQFM-UHFFFAOYSA-N furo[3,4-c]pyridine-1,3-dione Chemical compound N1=CC=C2C(=O)OC(=O)C2=C1 KFKMGUPDWTWQFM-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000005337 ground glass Substances 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 description 1
- SKVRYQUMKJQZFN-UHFFFAOYSA-N hydron;2-(hydroxymethyl)pyridin-3-ol;chloride Chemical compound Cl.OCC1=NC=CC=C1O SKVRYQUMKJQZFN-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 239000003326 hypnotic agent Substances 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- SFXQJROVECIHKO-UHFFFAOYSA-N methyl 5,5-dimethyl-2-oxocyclohexane-1-carboxylate Chemical compound COC(=O)C1CC(C)(C)CCC1=O SFXQJROVECIHKO-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- TWIIRMSFZNYMQE-UHFFFAOYSA-N methyl pyrazine-2-carboxylate Chemical compound COC(=O)C1=CN=CC=N1 TWIIRMSFZNYMQE-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- AEXITZJSLGALNH-UHFFFAOYSA-N n'-hydroxyethanimidamide Chemical compound CC(N)=NO AEXITZJSLGALNH-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 238000012587 nuclear overhauser effect experiment Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000012053 oil suspension Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000013110 organic ligand Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- LXNAVEXFUKBNMK-UHFFFAOYSA-N palladium(II) acetate Substances [Pd].CC(O)=O.CC(O)=O LXNAVEXFUKBNMK-UHFFFAOYSA-N 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229960005152 pentetrazol Drugs 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000008024 pharmaceutical diluent Substances 0.000 description 1
- 125000000286 phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- 208000019899 phobic disease Diseases 0.000 description 1
- UXCDUFKZSUBXGM-UHFFFAOYSA-N phosphoric tribromide Chemical compound BrP(Br)(Br)=O UXCDUFKZSUBXGM-UHFFFAOYSA-N 0.000 description 1
- VVZNYMSMDNYBQQ-UHFFFAOYSA-N phthalazin-3-ium;chloride Chemical compound Cl.C1=NN=CC2=CC=CC=C21 VVZNYMSMDNYBQQ-UHFFFAOYSA-N 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 208000028173 post-traumatic stress disease Diseases 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
- BWTWGDGOQAUAJQ-UHFFFAOYSA-M potassium;[3-(cyclopropylmethoxy)pyridin-2-yl]methanol;hydroxide Chemical compound [OH-].[K+].OCC1=NC=CC=C1OCC1CC1 BWTWGDGOQAUAJQ-UHFFFAOYSA-M 0.000 description 1
- 238000004237 preparative chromatography Methods 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- BYUMAPPWWKNLNX-UHFFFAOYSA-N pyrazol-1-ylmethanol Chemical compound OCN1C=CC=N1 BYUMAPPWWKNLNX-UHFFFAOYSA-N 0.000 description 1
- TVPRCLHSULCNLV-UHFFFAOYSA-N pyridazin-3-one Chemical compound O=C1C=CC=N[N]1 TVPRCLHSULCNLV-UHFFFAOYSA-N 0.000 description 1
- YTRGNBTVTHPFJM-UHFFFAOYSA-N pyridazin-3-ylhydrazine Chemical compound NNC1=CC=CN=N1 YTRGNBTVTHPFJM-UHFFFAOYSA-N 0.000 description 1
- QEGHEEOQRPNAOD-UHFFFAOYSA-N pyridin-2-ylmethanol;hydrate Chemical compound O.OCC1=CC=CC=N1 QEGHEEOQRPNAOD-UHFFFAOYSA-N 0.000 description 1
- ABMYEXAYWZJVOV-UHFFFAOYSA-N pyridin-3-ylboronic acid Chemical compound OB(O)C1=CC=CN=C1 ABMYEXAYWZJVOV-UHFFFAOYSA-N 0.000 description 1
- PTMBWNZJOQBTBK-UHFFFAOYSA-N pyridin-4-ylmethanol Chemical compound OCC1=CC=NC=C1 PTMBWNZJOQBTBK-UHFFFAOYSA-N 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000005932 reductive alkylation reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 102200015516 rs4784677 Human genes 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- 239000001476 sodium potassium tartrate Substances 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 229950009390 symclosene Drugs 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229960003188 temazepam Drugs 0.000 description 1
- JNYVFHASMHPMFL-UHFFFAOYSA-N tert-butyl-(1h-imidazol-5-ylmethoxy)-dimethylsilane Chemical compound CC(C)(C)[Si](C)(C)OCC1=CNC=N1 JNYVFHASMHPMFL-UHFFFAOYSA-N 0.000 description 1
- XKQMRIVZVLGFFZ-UHFFFAOYSA-N tert-butyl-dimethyl-(1h-1,2,4-triazol-5-ylmethoxy)silane Chemical compound CC(C)(C)[Si](C)(C)OCC1=NC=NN1 XKQMRIVZVLGFFZ-UHFFFAOYSA-N 0.000 description 1
- AWDWFKCXUYBBNR-UHFFFAOYSA-N tert-butyl-dimethyl-[(1-propyl-1,2,4-triazol-3-yl)methoxy]silane Chemical compound CCCN1C=NC(CO[Si](C)(C)C(C)(C)C)=N1 AWDWFKCXUYBBNR-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000005301 thienylmethyl group Chemical group [H]C1=C([H])C([H])=C(S1)C([H])([H])* 0.000 description 1
- BRNULMACUQOKMR-UHFFFAOYSA-N thiomorpholine Chemical compound C1CSCCN1 BRNULMACUQOKMR-UHFFFAOYSA-N 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- SANWDQJIWZEKOD-UHFFFAOYSA-N tributyl(furan-2-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=CO1 SANWDQJIWZEKOD-UHFFFAOYSA-N 0.000 description 1
- UKTDFYOZPFNQOQ-UHFFFAOYSA-N tributyl(thiophen-2-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CC=CS1 UKTDFYOZPFNQOQ-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- DHWQQVXDRKXOCV-UHFFFAOYSA-N trimethyl-[2-(1,2,4-triazol-1-ylmethoxy)ethyl]silane Chemical compound C[Si](C)(C)CCOCN1C=NC=N1 DHWQQVXDRKXOCV-UHFFFAOYSA-N 0.000 description 1
- RZLMQJSSMROKSS-UHFFFAOYSA-N trimethyl-[2-(triazol-1-ylmethoxy)ethyl]silane Chemical compound C[Si](C)(C)CCOCN1C=CN=N1 RZLMQJSSMROKSS-UHFFFAOYSA-N 0.000 description 1
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229960001475 zolpidem Drugs 0.000 description 1
- ZAFYATHCZYHLPB-UHFFFAOYSA-N zolpidem Chemical compound N1=C2C=CC(C)=CN2C(CC(=O)N(C)C)=C1C1=CC=C(C)C=C1 ZAFYATHCZYHLPB-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9615645.0A GB9615645D0 (en) | 1996-07-25 | 1996-07-25 | Therapeutic agents |
GB9615645.0 | 1996-07-25 | ||
GB9625397.6 | 1996-12-06 | ||
GBGB9625397.6A GB9625397D0 (en) | 1996-12-06 | 1996-12-06 | Therapeutic agents |
GBGB9714420.8A GB9714420D0 (en) | 1997-07-09 | 1997-07-09 | Therapeutic agents |
GB9714420.8 | 1997-07-09 | ||
PCT/GB1997/001946 WO1998004559A2 (fr) | 1996-07-25 | 1997-07-17 | Derives de triazolo-pyridazine substitues servant de ligands pour recepteurs de gaba |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2260774A1 CA2260774A1 (fr) | 1998-02-05 |
CA2260774C true CA2260774C (fr) | 2007-07-03 |
Family
ID=38280590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002260774A Expired - Fee Related CA2260774C (fr) | 1996-07-25 | 1997-07-17 | Derives de triazolo-pyridazine substitues servant de ligands pour recepteurs de gaba |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2260774C (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113009014B (zh) * | 2021-02-24 | 2023-04-07 | 上海旭东海普药业有限公司 | 一种2-甲氧基-5-氟尿嘧啶杂质的高效液相检测方法 |
-
1997
- 1997-07-17 CA CA002260774A patent/CA2260774C/fr not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2260774A1 (fr) | 1998-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6255305B1 (en) | Substituted triazolo-pyridazine derivatives as ligands for GABA receptors | |
US6476030B1 (en) | Pyrazolo-triazine derivatives as ligands for GABA receptors | |
JP2009506004A (ja) | p38MAPキナーゼ阻害剤としての縮合ピラゾール | |
CA2324266A1 (fr) | Derives de pyrazolo-pyridine servant de ligands pour des recepteurs gaba | |
CA2315763A1 (fr) | Derives de la triazolo-pyridazine, ligands des recepteurs du gaba | |
WO1999006407A1 (fr) | Derives de 1,2,4-triazolo(4,3-b) pyridazine therapeutiquement actifs utilises comme ligands de recepteurs gaba | |
US6872720B2 (en) | Pyrazolo-triazine derivatives as ligands for gaba receptors | |
US6319924B1 (en) | Triazolo-pyridazine derivatives as ligands for GABA receptors | |
US7381725B2 (en) | Pyridazine derivatives as ligands for GABA receptors | |
AU747346B2 (en) | Triazolo-pyridazine derivatives as ligands for gaba receptors | |
US6297235B1 (en) | Triazolopyridazine derivatives for treating anxiety and enhancing cognition | |
US6699859B1 (en) | Triazolo-pyridazine derivatives as ligands for GABA receptors | |
CA2260774C (fr) | Derives de triazolo-pyridazine substitues servant de ligands pour recepteurs de gaba | |
US6613766B1 (en) | Pentaaza-cyclopental[a]naphthalene derivatives as ligands for GABAa α5 receptors | |
JP2003514909A (ja) | 認識能力増強用ピラゾロ〔1,5−d〕〔1,2,4〕トリアジン | |
US6444666B1 (en) | Triazolopyridazine Derivatives for treating anxiety and enhancing cognition | |
MXPA99000990A (en) | Substituted triazolo-pyridazine derivatives as ligands for gaba receptors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20150717 |